SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-04-08 16:18
Tx date 2024-03-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-53,000 vol
0
Filed 2024-04-08 16:14
Tx date 2024-03-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$158,950
+18,700 vol
$8.50 each
53,000
Filed 2024-04-08 16:13
Tx date 2024-03-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,875
+2,500 vol
$8.75 each
34,300
Filed 2024-04-08 16:11
Tx date 2024-03-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,625
+2,500 vol
$8.65 each
31,800
Filed 2024-04-08 16:09
Tx date 2024-03-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,625
+2,500 vol
$8.65 each
29,300
Filed 2024-04-08 16:07
Tx date 2024-03-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,625
+2,500 vol
$8.65 each
26,800
Filed 2024-04-08 16:05
Tx date 2024-03-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,500
+2,500 vol
$8.60 each
24,300
Filed 2024-04-08 16:02
Tx date 2024-03-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,699
+2,500 vol
$8.68 each
21,800
Filed 2024-04-08 16:01
Tx date 2024-03-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,625
+2,500 vol
$8.65 each
19,300
Filed 2024-04-08 15:58
Tx date 2024-03-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,675
+2,500 vol
$8.67 each
16,800
Filed 2024-04-08 15:56
Tx date 2024-03-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$43,240
+5,000 vol
$8.65 each
14,300
Filed 2024-04-08 15:55
Tx date 2024-03-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,472
+2,400 vol
$8.53 each
9,300
Filed 2024-04-08 15:52
Tx date 2024-03-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$851.00
+100 vol
$8.51 each
6,900
Filed 2024-04-02 18:36
Tx date 2024-03-27
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+17,103 vol
999,492
Filed 2024-04-02 18:35
Tx date 2024-03-19
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$79,305
+9,330 vol
$8.50 each
982,389
Filed 2024-04-02 18:34
Tx date 2024-03-19
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-18,661 vol
973,059
Filed 2024-04-02 18:28
Tx date 2023-12-31
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,974
+1,164 vol
$7.71 each
991,720
Filed 2024-04-02 18:27
Tx date 2023-12-31
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$20,343
+2,625 vol
$7.75 each
990,556
Filed 2024-04-02 11:25
Tx date 2024-04-01
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$5,492
+632 vol
$8.69 each
179,796
Filed 2024-04-02 11:23
Tx date 2024-04-01
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-1,264 vol
179,164
Filed 2024-04-02 09:56
Tx date 2024-04-01
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,373
+158 vol
$8.69 each
10,315
Filed 2024-04-02 09:55
Tx date 2024-04-01
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+317 vol
10,157
Filed 2024-04-02 09:32
Tx date 2024-04-01
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
$2,528
+291 vol
$8.69 each
12,272
Filed 2024-04-02 09:30
Tx date 2024-04-01
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-583 vol
11,981
Filed 2024-03-30 09:00
Tx date 2024-03-27
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+1,293 vol
9,840
Filed 2024-03-29 14:02
Tx date 2024-03-27
$RX
BioSyent Inc.
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+3,195 vol
17,502
Filed 2024-03-29 14:01
Tx date 2024-03-19
$RX
BioSyent Inc.
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$14,637
+1,722 vol
$8.50 each
14,307
Filed 2024-03-29 14:00
Tx date 2024-03-19
$RX
BioSyent Inc.
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-3,444 vol
12,585
Filed 2024-03-28 17:29
Tx date 2024-03-28
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,837.20
-556 vol
$8.70 each
180,428
Filed 2024-03-28 15:35
Tx date 2024-03-28
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,700
+1,000 vol
$8.70 each
9,684
Filed 2024-03-28 15:32
Tx date 2024-03-28
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,700
+1,000 vol
$8.70 each
8,684
Filed 2024-03-28 14:35
Tx date 2024-03-27
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+3,671 vol
41,994
Filed 2024-03-28 10:03
Tx date 2024-03-27
$RX
BioSyent Inc.
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+1,193 vol
2,600
Filed 2024-03-28 09:33
Tx date 2024-03-27
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+4,074 vol
48,038
Filed 2024-03-28 08:48
Tx date 2024-03-27
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+6,438 vol
52,730
Filed 2024-03-28 08:45
Tx date 2024-03-27
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+3,108 vol
20,175
Filed 2024-03-28 07:55
Tx date 2024-03-27
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+4,074 vol
65,664
Filed 2024-03-27 20:03
Tx date 2024-03-27
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+5,173 vol
180,984
Filed 2024-03-27 19:48
Tx date 2024-03-27
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+2,385 vol
12,564
Filed 2024-03-27 19:20
Tx date 2024-03-27
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$57,689
+6,631 vol
$8.70 each
56,254
Filed 2024-03-27 12:36
Tx date 2024-03-26
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,220
-600 vol
$8.70 each
175,811
Filed 2024-03-27 07:03
Tx date 2024-03-24
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$19,278
+2,268 vol
$8.50 each
61,590
Filed 2024-03-27 07:01
Tx date 2024-03-20
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-4,537 vol
59,322
Filed 2024-03-27 06:57
Tx date 2023-12-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,166
+281 vol
$7.71 each
63,859
Filed 2024-03-27 06:55
Tx date 2023-12-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,772
+1,261 vol
$7.75 each
63,578
Filed 2024-03-25 13:07
Tx date 2023-12-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,166
+281 vol
$7.71 each
46,233
Filed 2024-03-25 13:04
Tx date 2023-12-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$18,088
+2,337 vol
$7.74 each
45,952
Filed 2024-03-25 08:03
Tx date 2023-12-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+440 vol
49,814
Filed 2024-03-25 08:01
Tx date 2023-12-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+1,444 vol
49,374
Filed 2024-03-25 07:58
Tx date 2024-03-19
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,521 vol
44,408
Filed 2024-03-25 07:56
Tx date 2024-03-19
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-7,043 vol
40,887
Filed 2024-03-24 10:00
Tx date 2023-12-31
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$770.28
+98 vol
$7.86 each
7,680
Filed 2024-03-24 09:59
Tx date 2023-12-31
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,616
+211 vol
$7.66 each
7,582
Filed 2024-03-21 14:10
Tx date 2024-03-19
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$19,278
+2,268 vol
$8.50 each
41,346
Filed 2024-03-21 14:05
Tx date 2024-03-19
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-4,537 vol
39,078
Filed 2024-03-20 16:00
Tx date 2023-12-31
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$840.72
+113 vol
$7.44 each
8,751
Filed 2024-03-20 15:59
Tx date 2023-12-31
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,971
+649 vol
$7.66 each
8,638
Filed 2024-03-20 15:55
Tx date 2024-01-04
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,222
+136 vol
$8.99 each
Filed 2024-03-20 15:55
Tx date 2023-12-20
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$61.95
+7 vol
$8.85 each
Filed 2024-03-20 15:55
Tx date 2023-10-13
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,218
+151 vol
$8.07 each
Filed 2024-03-20 15:55
Tx date 2023-09-19
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$54.95
+7 vol
$7.85 each
Filed 2024-03-20 15:55
Tx date 2023-07-06
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,145
+153 vol
$7.49 each
Filed 2024-03-20 15:54
Tx date 2023-06-20
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$43.86
+6 vol
$7.31 each
Filed 2024-03-20 15:54
Tx date 2023-04-11
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,221
+161 vol
$7.59 each
Filed 2024-03-20 15:54
Tx date 2023-03-17
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$36.50
+5 vol
$7.30 each
Filed 2024-03-20 15:53
Tx date 2023-01-18
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,130
+151 vol
$7.49 each
Filed 2024-03-20 13:53
Tx date 2024-03-19
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$12,197
+1,435 vol
$8.50 each
17,067
Filed 2024-03-20 13:51
Tx date 2024-03-19
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-2,870 vol
15,632
Filed 2024-03-20 13:48
Tx date 2023-12-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,491
+194 vol
$7.69 each
18,502
Filed 2024-03-20 13:45
Tx date 2023-12-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,347
+948 vol
$7.75 each
18,308
Filed 2024-03-20 12:58
Tx date 2024-03-19
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$17,569
+2,067 vol
$8.50 each
38,323
Filed 2024-03-20 12:56
Tx date 2024-03-19
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+4,134 vol
36,256
Filed 2024-03-20 12:52
Tx date 2023-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,960
+253 vol
$7.75 each
32,122
Filed 2024-03-20 12:48
Tx date 2023-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,284
+1,069 vol
$7.75 each
31,869
Filed 2024-03-20 09:08
Tx date 2024-03-19
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$31,246
+3,676 vol
$8.50 each
49,623
Filed 2024-03-20 09:07
Tx date 2024-03-19
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-7,352 vol
45,947
Filed 2024-02-09 14:04
Tx date 2024-01-04
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,222
+136 vol
$8.99 each
Filed 2024-02-09 14:01
Tx date 2023-12-20
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$61.95
+7 vol
$8.85 each
Filed 2024-02-09 13:59
Tx date 2023-10-13
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,218
+151 vol
$8.07 each
Filed 2024-02-09 13:57
Tx date 2023-09-19
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$54.95
+7 vol
$7.85 each
Filed 2024-02-09 13:56
Tx date 2023-07-06
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,145
+153 vol
$7.49 each
Filed 2024-02-09 13:54
Tx date 2023-06-20
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$43.86
+6 vol
$7.31 each
Filed 2024-02-09 13:53
Tx date 2023-04-11
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,221
+161 vol
$7.59 each
Filed 2024-02-09 13:50
Tx date 2023-03-17
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$36.50
+5 vol
$7.30 each
Filed 2024-02-09 13:48
Tx date 2023-01-18
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,130
+151 vol
$7.49 each
Filed 2024-03-19 13:01
Tx date 2023-12-31
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
$1,842
+245 vol
$7.52 each
11,246
Filed 2024-03-19 11:27
Tx date 2024-03-15
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,078
+403 vol
$7.64 each
176,411
Filed 2024-03-19 10:07
Tx date 2023-12-31
$RX
BioSyent Inc.
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,673
+217 vol
$7.71 each
16,029
Filed 2024-03-19 10:06
Tx date 2023-12-31
$RX
BioSyent Inc.
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,602
+981 vol
$7.75 each
15,812
Filed 2024-03-19 09:40
Tx date 2023-12-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,509
+454 vol
$7.73 each
53,299
Filed 2024-03-19 09:39
Tx date 2023-12-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$28,582
+3,688 vol
$7.75 each
52,845
Filed 2024-03-08 13:40
Tx date 2024-02-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-13,200 vol
6,800
Filed 2024-03-08 13:39
Tx date 2024-02-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-37,500 vol
17,500
Filed 2024-03-08 13:36
Tx date 2024-02-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,584
+2,500 vol
$8.63 each
20,000
Filed 2024-03-08 13:34
Tx date 2024-02-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,851
+4,300 vol
$8.57 each
55,000
Filed 2024-03-08 13:33
Tx date 2024-02-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,846
+2,200 vol
$8.57 each
50,700
Filed 2024-03-08 13:32
Tx date 2024-02-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$49,194
+5,700 vol
$8.63 each
48,500
Filed 2024-03-08 13:31
Tx date 2024-02-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,541
+300 vol
$8.47 each
42,800
Filed 2024-03-08 13:29
Tx date 2024-02-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$43,300
+5,000 vol
$8.66 each
42,500
Filed 2024-03-08 13:28
Tx date 2024-02-16
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,750
+2,500 vol
$8.70 each
37,500
Filed 2024-03-08 13:27
Tx date 2024-02-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,737
+2,500 vol
$8.69 each
35,000
Filed 2024-03-08 13:26
Tx date 2024-02-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,875
+2,500 vol
$8.75 each
32,500
Filed 2024-03-08 13:24
Tx date 2024-02-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,835
+2,500 vol
$8.73 each
30,000
Filed 2024-03-08 13:22
Tx date 2024-02-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$39,335
+4,500 vol
$8.74 each
27,500
Filed 2024-03-08 13:21
Tx date 2024-02-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,330
+500 vol
$8.66 each
23,000
Filed 2024-03-08 13:20
Tx date 2024-02-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,710
+2,500 vol
$8.68 each
22,500
Filed 2024-03-08 13:18
Tx date 2024-02-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,498
+2,800 vol
$8.75 each
20,000
Filed 2024-03-08 13:15
Tx date 2024-02-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,986
+2,200 vol
$8.63 each
17,200
Filed 2024-03-08 13:14
Tx date 2024-02-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,500
+2,500 vol
$8.60 each
15,000
Filed 2024-03-08 13:12
Tx date 2024-02-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,495
+2,500 vol
$8.60 each
12,500
Filed 2024-03-08 13:09
Tx date 2024-02-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,500
+2,500 vol
$8.60 each
10,000
Filed 2024-01-06 08:38
Tx date 2024-01-02
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$9,540
+1,066 vol
$8.95 each
6,922
Filed 2024-01-06 08:31
Tx date 2024-01-02
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-2,133 vol
5,856
Filed 2024-01-03 12:37
Tx date 2024-01-02
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$10,346
+1,156 vol
$8.95 each
176,008
Filed 2024-01-03 12:35
Tx date 2024-01-02
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-2,313 vol
174,852
Filed 2024-01-03 11:28
Tx date 2003-10-30
$RX
Hedley Technologies Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$25,000
+100,000 vol
$0.25 each
Filed 2024-01-03 11:25
Tx date 2024-01-02
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$2,586
+289 vol
$8.95 each
8,238
Filed 2024-01-03 11:24
Tx date 2024-01-02
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$2,506
+280 vol
$8.95 each
Filed 2024-01-03 11:23
Tx date 2024-01-02
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+578 vol
7,949
Filed 2024-01-03 10:48
Tx date 2024-01-02
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
$9,540
+1,066 vol
$8.95 each
9,934
Filed 2024-01-03 10:45
Tx date 2024-01-02
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,133 vol
8,868
Filed 2024-01-03 09:58
Tx date 2023-12-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-68,700 vol
6,000
Filed 2024-01-03 09:57
Tx date 2023-12-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$53,641
+6,000 vol
$8.94 each
74,700
Filed 2024-01-03 09:56
Tx date 2023-12-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$29,205
+3,300 vol
$8.85 each
68,700
Filed 2024-01-03 09:55
Tx date 2023-12-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$92,750
+10,600 vol
$8.75 each
65,400
Filed 2024-01-03 09:55
Tx date 2023-12-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,723
+200 vol
$8.62 each
54,800
Filed 2024-01-03 09:54
Tx date 2023-12-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$194,967
+22,800 vol
$8.55 each
54,600
Filed 2024-01-03 09:53
Tx date 2023-12-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$83,298
+9,800 vol
$8.50 each
31,800
Filed 2024-01-03 09:53
Tx date 2023-12-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,800
+2,000 vol
$8.40 each
22,000
Filed 2024-01-03 09:52
Tx date 2023-12-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$93,240
+11,100 vol
$8.40 each
20,000
Filed 2024-01-03 09:51
Tx date 2023-12-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$34,285
+4,100 vol
$8.36 each
8,900
Filed 2024-01-03 09:46
Tx date 2024-01-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
97 - Other
$-32,014.15
-3,577 vol
$8.95 each
203,766
Filed 2024-01-03 09:45
Tx date 2023-10-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
97 - Other
$-27,958.02
-3,557 vol
$7.86 each
207,343
Filed 2004-04-20 10:21
Tx date 2003-10-30
$RX
Hedley Technologies Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$25,000
+100,000 vol
$0.25 each
Filed 2004-04-14 14:23
Tx date 2003-10-30
$RX
Hedley Technologies Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options

+100,000 vol
Filed 2023-12-08 17:09
Tx date 2023-12-08
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-49,300
-5,800 vol
$8.50 each
43,615
Filed 2023-12-08 17:08
Tx date 2023-12-06
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-70,958
-8,348 vol
$8.50 each
49,415
Filed 2023-12-08 17:07
Tx date 2023-12-06
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$20,300
+2,762 vol
$7.35 each
57,763
Filed 2023-12-08 17:06
Tx date 2023-12-06
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$12,443
+2,007 vol
$6.20 each
55,001
Filed 2023-12-08 17:05
Tx date 2023-12-06
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-20,300.70
-2,762 vol
$7.35 each
5,836
Filed 2023-12-08 17:04
Tx date 2023-12-06
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-12,443.40
-2,007 vol
$6.20 each
8,598
Filed 2023-12-08 17:02
Tx date 2023-12-06
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$26,663
+3,579 vol
$7.45 each
52,994
Filed 2023-12-08 16:59
Tx date 2023-12-06
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$26,663
+3,579 vol
$7.45 each
14,184
Filed 2023-12-08 16:59
Tx date 2023-12-06
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$26,663
+3,579 vol
$7.45 each
Filed 2023-12-08 16:58
Tx date 2023-12-06
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-26,663.55
-3,579 vol
$7.45 each
10,605
Filed 2023-12-04 11:25
Tx date 2023-11-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-18,700 vol
4,800
Filed 2023-12-04 11:24
Tx date 2023-11-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$40,320
+4,800 vol
$8.40 each
23,500
Filed 2023-12-04 11:23
Tx date 2023-11-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$820.00
+100 vol
$8.20 each
18,700
Filed 2023-12-04 11:23
Tx date 2023-11-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$820.00
+100 vol
$8.20 each
18,600
Filed 2023-12-04 11:22
Tx date 2023-11-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$147,659
+18,000 vol
$8.20 each
18,500
Filed 2023-12-04 11:22
Tx date 2023-11-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$775.00
+100 vol
$7.75 each
500
Filed 2023-12-04 11:21
Tx date 2023-11-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,100
+400 vol
$7.75 each
400
Filed 2023-11-29 14:50
Tx date 2023-11-27
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,500
-1,000 vol
$8.50 each
49,415
Filed 2023-11-29 14:49
Tx date 2023-11-27
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$7,450
+1,000 vol
$7.45 each
50,415
Filed 2023-11-29 14:47
Tx date 2023-11-27
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-7,450
-1,000 vol
$7.45 each
14,184
Filed 2023-10-05 17:51
Tx date 2023-10-02
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$8,339
+1,061 vol
$7.86 each
7,989
Filed 2023-10-05 17:48
Tx date 2023-10-02
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-2,123 vol
6,928
Filed 2023-10-05 07:27
Tx date 2023-10-02
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$9,023
+1,148 vol
$7.86 each
177,165
Filed 2023-10-05 07:25
Tx date 2023-10-02
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-2,297 vol
176,017
Filed 2023-10-04 13:43
Tx date 2023-10-02
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
$8,339
+1,061 vol
$7.86 each
11,001
Filed 2023-10-04 13:40
Tx date 2023-10-02
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,123 vol
9,940
Filed 2023-10-04 09:14
Tx date 2023-10-02
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$2,255
+287 vol
$7.86 each
107,371
Filed 2023-09-05 16:03
Tx date 2023-08-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-39,300 vol
0
Filed 2023-09-05 16:03
Tx date 2023-08-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,084
+3,700 vol
$7.59 each
39,300
Filed 2023-09-05 16:02
Tx date 2023-08-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,952
+2,900 vol
$7.57 each
35,600
Filed 2023-09-05 16:02
Tx date 2023-08-17
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,456
+4,800 vol
$7.60 each
32,700
Filed 2023-09-05 16:01
Tx date 2023-08-16
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,320
+700 vol
$7.60 each
27,900
Filed 2023-09-05 16:00
Tx date 2023-08-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,080
+800 vol
$7.60 each
27,200
Filed 2023-09-05 15:59
Tx date 2023-08-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,800
+500 vol
$7.60 each
26,400
Filed 2023-09-05 15:59
Tx date 2023-08-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,320
+700 vol
$7.60 each
25,900
Filed 2023-09-05 15:58
Tx date 2023-08-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,440
+1,900 vol
$7.60 each
25,200
Filed 2023-09-05 15:57
Tx date 2023-08-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$760.00
+100 vol
$7.60 each
23,300
Filed 2023-09-05 15:57
Tx date 2023-08-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,239
+4,400 vol
$7.55 each
23,200
Filed 2023-09-05 15:56
Tx date 2023-08-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,440
+1,900 vol
$7.60 each
18,800
Filed 2023-09-05 15:55
Tx date 2023-08-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,040
+800 vol
$7.55 each
16,900
Filed 2023-09-05 15:54
Tx date 2023-08-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,480
+4,800 vol
$7.60 each
16,100
Filed 2023-09-05 15:54
Tx date 2023-08-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$34,954
+4,600 vol
$7.60 each
11,300
Filed 2023-08-08 11:28
Tx date 2023-07-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-46,100 vol
6,700
Filed 2023-08-08 11:27
Tx date 2023-07-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,428
+1,800 vol
$7.46 each
52,800
Filed 2023-08-08 11:27
Tx date 2023-07-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,400
+1,500 vol
$7.60 each
51,000
Filed 2023-08-08 11:26
Tx date 2023-07-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,600
+1,000 vol
$7.60 each
49,500
Filed 2023-08-08 11:25
Tx date 2023-07-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,070
+2,400 vol
$7.53 each
48,500
Filed 2023-08-08 11:24
Tx date 2023-07-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,140
+2,800 vol
$7.55 each
46,100
Filed 2023-08-08 11:24
Tx date 2023-07-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$31,258
+4,200 vol
$7.44 each
43,300
Filed 2023-08-08 11:23
Tx date 2023-07-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,920
+1,600 vol
$7.45 each
39,100
Filed 2023-08-08 11:22
Tx date 2023-07-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$745.00
+100 vol
$7.45 each
37,500
Filed 2023-08-08 11:21
Tx date 2023-07-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$34,458
+4,600 vol
$7.49 each
37,400
Filed 2023-08-08 11:21
Tx date 2023-07-17
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,110
+1,600 vol
$7.57 each
32,800
Filed 2023-08-08 11:20
Tx date 2023-07-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$22,800
+3,000 vol
$7.60 each
31,200
Filed 2023-08-08 11:19
Tx date 2023-07-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,306
+700 vol
$7.58 each
28,200
Filed 2023-08-08 11:18
Tx date 2023-07-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,899
+3,700 vol
$7.54 each
27,500
Filed 2023-08-08 11:18
Tx date 2023-07-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$29,960
+4,000 vol
$7.49 each
23,800
Filed 2023-08-08 11:17
Tx date 2023-07-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$35,520
+4,800 vol
$7.40 each
19,800
Filed 2023-08-08 11:16
Tx date 2023-07-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$35,760
+4,800 vol
$7.45 each
15,000
Filed 2023-08-08 11:16
Tx date 2023-07-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$35,951
+4,800 vol
$7.49 each
10,200
Filed 2023-07-05 10:32
Tx date 2023-06-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
97 - Other
$-26,529.58
-3,542 vol
$7.49 each
210,900
Filed 2023-07-05 10:31
Tx date 2023-06-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$73,725
+10,000 vol
$7.37 each
214,442
Filed 2023-07-05 10:30
Tx date 2023-06-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$49,939
+6,800 vol
$7.34 each
204,442
Filed 2023-07-05 10:29
Tx date 2023-06-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$59,259
+8,200 vol
$7.23 each
197,642
Filed 2023-07-05 10:28
Tx date 2023-03-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
97 - Other
$-388,935
-51,858 vol
$7.50 each
189,442
Filed 2023-07-05 10:09
Tx date 2023-06-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-163,500 vol
5,400
Filed 2023-07-05 10:08
Tx date 2023-06-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$39,859
+5,400 vol
$7.38 each
168,900
Filed 2023-07-05 10:07
Tx date 2023-06-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$271,990
+37,000 vol
$7.35 each
163,500
Filed 2023-07-05 10:07
Tx date 2023-06-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,474
+200 vol
$7.37 each
126,500
Filed 2023-07-05 10:06
Tx date 2023-06-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,160
+5,300 vol
$7.20 each
126,300
Filed 2023-07-05 10:05
Tx date 2023-06-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$74,880
+10,400 vol
$7.20 each
121,000
Filed 2023-07-05 10:04
Tx date 2023-06-16
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,360
+3,800 vol
$7.20 each
110,600
Filed 2023-07-05 10:04
Tx date 2023-06-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$15,840
+2,200 vol
$7.20 each
106,800
Filed 2023-07-05 10:03
Tx date 2023-06-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$23,760
+3,300 vol
$7.20 each
104,600
Filed 2023-07-05 10:03
Tx date 2023-06-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$319,725
+43,500 vol
$7.35 each
101,300
Filed 2023-07-05 10:02
Tx date 2023-06-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$42,630
+5,800 vol
$7.35 each
57,800
Filed 2023-07-05 10:01
Tx date 2023-06-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$198,450
+27,000 vol
$7.35 each
52,000
Filed 2023-07-05 10:01
Tx date 2023-06-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,760
+1,200 vol
$7.30 each
25,000
Filed 2023-07-05 10:00
Tx date 2023-06-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$66,394
+8,900 vol
$7.46 each
23,800
Filed 2023-07-05 09:59
Tx date 2023-06-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$67,104
+9,000 vol
$7.46 each
14,900
Filed 2023-07-05 09:59
Tx date 2023-06-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,820
+1,200 vol
$7.35 each
5,900
Filed 2023-07-05 09:58
Tx date 2023-06-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,190
+300 vol
$7.30 each
4,700
Filed 2023-07-04 12:38
Tx date 2023-06-30
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$7,909
+1,056 vol
$7.49 each
9,051
Filed 2023-07-04 12:36
Tx date 2023-06-30
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-2,112 vol
7,995
Filed 2023-07-04 09:01
Tx date 2023-06-30
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$2,142
+286 vol
$7.49 each
107,084
Filed 2023-07-04 09:00
Tx date 2023-06-30
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+573 vol
106,798
Filed 2023-07-01 08:15
Tx date 2023-06-30
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$8,568
+1,144 vol
$7.49 each
178,314
Filed 2023-07-01 08:14
Tx date 2023-06-30
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+2,289 vol
177,170
Filed 2023-06-30 17:52
Tx date 2023-06-30
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
$7,909
+1,056 vol
$7.49 each
12,063
Filed 2023-06-30 17:43
Tx date 2023-06-30
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,112 vol
11,007
Filed 2023-06-12 09:25
Tx date 2023-06-02
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-7,996.80
-1,088 vol
$7.35 each
62,317
Filed 2023-06-11 17:33
Tx date 2023-06-09
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+1,000 vol
47,930
Filed 2023-06-07 20:46
Tx date 2023-06-06
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+1,000 vol
46,930
Filed 2023-06-06 09:06
Tx date 2023-05-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,650
+500 vol
$7.30 each
4,400
Filed 2023-06-06 09:05
Tx date 2023-05-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,470
+3,900 vol
$7.30 each
3,900
Filed 2023-05-10 10:46
Tx date 2023-04-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-9,500 vol
0
Filed 2023-05-10 10:45
Tx date 2023-04-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,250
+5,000 vol
$7.25 each
9,500
Filed 2023-04-10 10:44
Tx date 2023-03-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-48,300 vol
4,500
Filed 2023-04-10 10:43
Tx date 2023-03-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,750
+4,500 vol
$7.50 each
52,800
Filed 2023-04-10 10:42
Tx date 2023-03-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$45,640
+6,100 vol
$7.48 each
48,300
Filed 2023-04-10 10:41
Tx date 2023-03-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$186,377
+25,100 vol
$7.43 each
42,200
Filed 2023-04-10 10:40
Tx date 2023-03-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$76,500
+10,200 vol
$7.50 each
17,100
Filed 2023-04-10 10:39
Tx date 2023-03-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$50,848
+6,900 vol
$7.37 each
6,900
Filed 2023-04-05 17:55
Tx date 2023-03-31
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+19,147 vol
987,931
Filed 2023-04-04 16:09
Tx date 2023-03-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$26,002
+3,467 vol
$7.50 each
17,360
Filed 2023-04-04 16:08
Tx date 2023-03-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$18,382
+2,451 vol
$7.50 each
13,893
Filed 2023-04-04 16:07
Tx date 2023-03-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$-36,765
-4,902 vol
$7.50 each
11,442
Filed 2023-04-03 11:18
Tx date 2023-03-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+4,587 vol
49,415
Filed 2023-04-03 10:40
Tx date 2023-03-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

-2,997 vol
14,831
Filed 2023-04-03 10:11
Tx date 2023-03-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+4,133 vol
30,800
Filed 2023-04-03 10:10
Tx date 2023-03-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,529 vol
26,667
Filed 2023-04-03 10:10
Tx date 2023-03-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-7,058 vol
23,138
Filed 2023-04-03 10:04
Tx date 2023-03-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+4,133 vol
30,196
Filed 2023-04-03 10:03
Tx date 2023-03-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,529 vol
26,063
Filed 2023-04-03 10:01
Tx date 2023-03-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+7,058 vol
22,534
Filed 2023-04-03 09:09
Tx date 2023-03-31
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+1,409 vol
106,225
Filed 2023-04-02 14:38
Tx date 2023-03-31
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+5,633 vol
174,881
Filed 2023-04-02 14:36
Tx date 2023-03-31
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,138 vol
169,248
Filed 2023-04-02 14:34
Tx date 2023-03-31
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-2,277 vol
168,110
Filed 2023-04-01 12:17
Tx date 2023-03-31
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,051 vol
10,107
Filed 2023-04-01 12:15
Tx date 2023-03-31
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-2,102 vol
9,056
Filed 2023-04-01 08:40
Tx date 2023-03-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$29,040
+3,872 vol
$7.50 each
63,405
Filed 2023-04-01 08:37
Tx date 2023-03-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-7,744 vol
59,533
Filed 2023-03-31 18:40
Tx date 2023-03-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+7,430 vol
49,157
Filed 2023-03-31 18:39
Tx date 2023-03-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$47,047
+6,273 vol
$7.50 each
41,727
Filed 2023-03-31 18:37
Tx date 2023-03-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-12,546 vol
35,454
Filed 2023-03-31 18:12
Tx date 2023-03-31
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+2,600 vol
13,119
Filed 2023-03-31 18:02
Tx date 2022-12-31
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,591
+366 vol
$7.08 each
968,784
Filed 2023-03-31 17:59
Tx date 2022-12-31
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$16,757
+2,074 vol
$8.08 each
968,418
Filed 2023-03-31 17:59
Tx date 2023-03-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+7,219 vol
45,930
Filed 2023-03-31 17:39
Tx date 2023-03-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+6,012 vol
38,711
Filed 2023-03-31 17:38
Tx date 2023-03-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-12,024 vol
32,699
Filed 2023-03-31 17:31
Tx date 2023-03-31
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$7,882
+1,051 vol
$7.50 each
15,151
Filed 2023-03-31 17:28
Tx date 2023-03-31
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-2,102 vol
10,519
Filed 2023-03-31 17:27
Tx date 2023-03-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$22,057
+2,941 vol
$7.50 each
17,828
Filed 2023-03-31 17:26
Tx date 2023-03-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-5,882 vol
14,887
Filed 2023-03-31 17:02
Tx date 2023-03-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$29,040
+3,872 vol
$7.50 each
44,828
Filed 2023-03-31 16:59
Tx date 2023-03-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

-7,744 vol
40,956
Filed 2023-03-27 09:42
Tx date 2022-12-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+137 vol
44,723
Filed 2023-03-27 09:37
Tx date 2022-12-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+1,162 vol
44,586
Filed 2023-03-24 17:00
Tx date 2022-12-31
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
$501.97
+71 vol
$7.07 each
12,621
Filed 2023-03-24 16:59
Tx date 2022-12-31
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$727.18
+103 vol
$7.06 each
170,387
Filed 2023-03-22 12:25
Tx date 2022-12-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,016
+143 vol
$7.11 each
48,000
Filed 2023-03-22 12:23
Tx date 2022-12-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$24,243
+2,993 vol
$8.10 each
47,857
Filed 2023-03-20 11:34
Tx date 2022-12-31
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$332.29
+47 vol
$7.07 each
11,158
Filed 2023-03-20 11:32
Tx date 2022-12-31
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,444
+531 vol
$8.37 each
11,111
Filed 2023-03-15 11:33
Tx date 2022-12-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$627.45
+89 vol
$7.05 each
67,277
Filed 2023-03-15 11:32
Tx date 2022-12-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,063
+998 vol
$8.08 each
67,188
Filed 2023-03-15 09:56
Tx date 2022-12-31
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$204.45
+29 vol
$7.05 each
104,816
Filed 2023-03-15 09:54
Tx date 2022-12-31
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,275
+152 vol
$8.39 each
104,787
Filed 2023-03-14 11:28
Tx date 2022-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$570.40
+80 vol
$7.13 each
15,476
Filed 2023-03-14 11:25
Tx date 2022-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,169
+884 vol
$8.11 each
15,396
Filed 2023-03-13 16:53
Tx date 2022-12-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$410.64
+58 vol
$7.08 each
16,344
Filed 2023-03-13 16:50
Tx date 2022-12-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$627.45
+89 vol
$7.05 each
48,700
Filed 2023-03-13 16:48
Tx date 2022-12-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,495
+681 vol
$8.07 each
16,286
Filed 2023-03-13 16:45
Tx date 2022-12-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$15,838
+1,953 vol
$8.11 each
48,611
Filed 2023-03-13 15:29
Tx date 2022-12-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$480.76
+68 vol
$7.07 each
20,769
Filed 2023-03-13 15:27
Tx date 2022-12-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,285
+777 vol
$8.09 each
20,701
Filed 2022-12-05 10:08
Tx date 2022-11-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-31,000 vol
0
Filed 2022-12-05 10:07
Tx date 2022-11-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,172
+1,800 vol
$7.32 each
31,000
Filed 2022-12-05 10:06
Tx date 2022-11-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$15,701
+2,100 vol
$7.48 each
29,200
Filed 2022-12-05 10:05
Tx date 2022-11-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,500
+2,900 vol
$7.41 each
27,100
Filed 2022-12-05 10:04
Tx date 2022-11-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,942
+2,900 vol
$7.22 each
24,200
Filed 2022-12-05 10:04
Tx date 2022-11-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$15,867
+2,200 vol
$7.21 each
21,300
Filed 2022-12-05 10:03
Tx date 2022-11-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$19,987
+2,900 vol
$6.89 each
19,100
Filed 2022-12-05 10:02
Tx date 2022-11-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,250
+2,900 vol
$6.98 each
16,200
Filed 2022-12-05 10:02
Tx date 2022-11-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,475
+2,900 vol
$7.41 each
13,300
Filed 2022-12-05 10:01
Tx date 2022-11-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,725
+2,900 vol
$7.49 each
10,400
Filed 2022-12-05 10:01
Tx date 2022-11-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,890
+2,900 vol
$7.55 each
7,500
Filed 2022-12-05 10:00
Tx date 2022-11-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,680
+800 vol
$7.10 each
4,600
Filed 2022-11-10 11:56
Tx date 2022-11-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-3,900 vol
3,800
Filed 2022-11-10 11:56
Tx date 2022-10-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-30,900 vol
7,700
Filed 2022-11-10 11:55
Tx date 2022-10-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,454
+2,900 vol
$7.05 each
38,600
Filed 2022-11-10 11:54
Tx date 2022-10-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,318
+900 vol
$7.02 each
35,700
Filed 2022-11-10 11:54
Tx date 2022-10-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,024
+1,000 vol
$7.02 each
34,800
Filed 2022-11-10 11:53
Tx date 2022-10-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,574
+2,900 vol
$7.09 each
33,800
Filed 2022-11-10 11:52
Tx date 2022-10-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,595
+2,900 vol
$7.45 each
30,900
Filed 2022-11-10 11:52
Tx date 2022-10-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,210
+2,900 vol
$7.31 each
28,000
Filed 2022-11-10 11:51
Tx date 2022-10-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,784
+2,900 vol
$7.17 each
25,100
Filed 2022-11-10 11:51
Tx date 2022-10-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,975
+1,100 vol
$7.25 each
22,200
Filed 2022-11-10 11:50
Tx date 2022-10-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,929
+2,900 vol
$7.22 each
21,100
Filed 2022-11-10 11:49
Tx date 2022-10-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,828
+400 vol
$7.07 each
18,200
Filed 2022-11-10 11:49
Tx date 2022-10-17
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$19,545
+2,900 vol
$6.74 each
17,800
Filed 2022-11-10 11:45
Tx date 2022-10-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$22,374
+2,900 vol
$7.72 each
14,900
Filed 2022-11-10 11:45
Tx date 2022-10-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,275
+2,100 vol
$7.75 each
12,000
Filed 2022-11-10 11:44
Tx date 2022-10-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,200
+800 vol
$7.75 each
9,900
Filed 2022-11-10 11:43
Tx date 2022-10-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,101
+1,200 vol
$7.58 each
9,100
Filed 2022-11-10 11:43
Tx date 2022-10-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,700
+2,900 vol
$7.48 each
7,900
Filed 2022-11-10 11:42
Tx date 2022-10-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$22,370
+2,900 vol
$7.71 each
5,000
Filed 2022-10-07 09:01
Tx date 2022-09-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-4,000 vol
2,100
Filed 2022-10-07 09:01
Tx date 2022-09-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-22,600 vol
6,100
Filed 2022-10-07 09:00
Tx date 2022-09-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,680
+600 vol
$7.80 each
28,700
Filed 2022-10-07 08:59
Tx date 2022-09-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,625
+1,500 vol
$7.75 each
28,100
Filed 2022-10-07 08:58
Tx date 2022-09-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,880
+4,000 vol
$7.72 each
26,600
Filed 2022-10-07 08:58
Tx date 2022-09-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$125,242
+16,200 vol
$7.73 each
22,600
Filed 2022-10-07 08:57
Tx date 2022-09-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,920
+2,700 vol
$7.75 each
6,400
Filed 2022-09-09 09:46
Tx date 2022-08-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-78,300 vol
3,700
Filed 2022-09-09 09:45
Tx date 2022-08-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$29,550
+3,700 vol
$7.99 each
82,000
Filed 2022-09-09 09:43
Tx date 2022-08-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$31,192
+3,900 vol
$8.00 each
78,300
Filed 2022-09-09 09:43
Tx date 2022-08-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$72,619
+9,100 vol
$7.98 each
74,400
Filed 2022-09-09 09:42
Tx date 2022-08-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$31,982
+4,000 vol
$8.00 each
65,300
Filed 2022-09-09 09:41
Tx date 2022-08-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,794
+600 vol
$7.99 each
61,300
Filed 2022-09-09 09:40
Tx date 2022-08-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$31,986
+4,000 vol
$8.00 each
60,700
Filed 2022-09-09 09:40
Tx date 2022-08-17
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$64,000
+8,000 vol
$8.00 each
56,700
Filed 2022-09-09 09:39
Tx date 2022-08-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,000
+2,500 vol
$8.00 each
48,700
Filed 2022-09-09 09:39
Tx date 2022-08-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$64,020
+8,000 vol
$8.00 each
46,200
Filed 2022-09-09 09:38
Tx date 2022-08-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,204
+400 vol
$8.01 each
38,200
Filed 2022-09-09 09:37
Tx date 2022-08-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$801.00
+100 vol
$8.01 each
37,800
Filed 2022-09-09 09:37
Tx date 2022-08-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,000
+3,000 vol
$8.00 each
37,700
Filed 2022-09-09 09:36
Tx date 2022-08-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,873
+3,900 vol
$7.92 each
34,700
Filed 2022-09-09 09:36
Tx date 2022-08-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,960
+1,000 vol
$7.96 each
30,800
Filed 2022-09-09 09:35
Tx date 2022-08-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,752
+1,600 vol
$7.97 each
29,800
Filed 2022-09-09 09:29
Tx date 2022-08-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$215,989
+27,000 vol
$8.00 each
28,200
Filed 2022-09-09 09:27
Tx date 2022-08-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$46,818
+5,850 vol
$8.00 each
241,300
Filed 2022-09-09 09:27
Tx date 2022-08-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$26,550
+3,325 vol
$7.99 each
235,450
Filed 2022-08-10 16:16
Tx date 2022-07-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,396
+2,675 vol
$8.00 each
232,125
Filed 2022-08-10 16:15
Tx date 2022-07-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$26,747
+3,350 vol
$7.98 each
229,450
Filed 2022-08-10 16:13
Tx date 2022-07-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-25,000 vol
1,200
Filed 2022-08-10 16:12
Tx date 2022-07-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,600
+1,200 vol
$8.00 each
26,200
Filed 2022-08-10 16:11
Tx date 2022-07-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-50,800 vol
25,000
Filed 2022-08-10 16:10
Tx date 2022-07-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$200,220
+25,000 vol
$8.01 each
75,800
Filed 2022-08-10 16:09
Tx date 2022-07-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$801.00
+100 vol
$8.01 each
50,800
Filed 2022-08-10 16:09
Tx date 2022-07-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,408
+800 vol
$8.01 each
50,700
Filed 2022-08-10 16:08
Tx date 2022-07-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,015
+1,500 vol
$8.01 each
49,900
Filed 2022-08-10 16:07
Tx date 2022-07-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$25,632
+3,200 vol
$8.01 each
48,400
Filed 2022-08-10 16:06
Tx date 2022-07-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$37,497
+4,700 vol
$7.98 each
45,200
Filed 2022-08-10 16:05
Tx date 2022-07-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,418
+1,800 vol
$8.01 each
40,500
Filed 2022-08-10 16:04
Tx date 2022-07-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,397
+4,800 vol
$8.00 each
38,700
Filed 2022-08-10 16:04
Tx date 2022-07-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,821
+2,100 vol
$8.01 each
33,900
Filed 2022-08-10 16:03
Tx date 2022-07-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,204
+400 vol
$8.01 each
31,800
Filed 2022-08-10 16:02
Tx date 2022-07-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,408
+1,300 vol
$8.01 each
31,400
Filed 2022-08-10 16:02
Tx date 2022-07-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,995
+1,000 vol
$8.00 each
30,100
Filed 2022-07-10 08:42
Tx date 2022-06-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$212,127
+27,200 vol
$7.80 each
29,100
Filed 2022-07-10 08:42
Tx date 2022-06-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,801
+1,900 vol
$7.79 each
1,900
Filed 2022-07-10 08:41
Tx date 2022-06-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-900 vol
0
Filed 2022-07-10 08:40
Tx date 2022-06-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,975
+900 vol
$7.75 each
900
Filed 2022-07-10 08:40
Tx date 2022-06-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-28,100 vol
0
Filed 2022-07-10 08:39
Tx date 2022-06-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$35,946
+4,500 vol
$7.99 each
28,100
Filed 2022-07-10 08:38
Tx date 2022-06-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,642
+4,200 vol
$8.01 each
23,600
Filed 2022-07-10 08:38
Tx date 2022-06-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,826
+2,600 vol
$8.01 each
19,400
Filed 2022-07-10 08:37
Tx date 2022-06-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$56,871
+7,100 vol
$8.01 each
16,800
Filed 2022-07-10 08:36
Tx date 2022-06-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,408
+800 vol
$8.01 each
9,700
Filed 2022-07-10 08:35
Tx date 2022-06-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$56,871
+7,100 vol
$8.01 each
8,900
Filed 2022-07-10 08:35
Tx date 2022-06-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,418
+1,800 vol
$8.01 each
1,800
Filed 2022-07-04 10:33
Tx date 2022-06-30
$RX
BioSyent Inc.
Driscoll, Sean
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$194,750
+25,000 vol
$7.79 each
2,146,100
Filed 2022-07-04 10:31
Tx date 2022-06-30
$RX
BioSyent Inc.
Driscoll, Merrilyn Joy
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$194,750
+25,000 vol
$7.79 each
2,146,100
Filed 2022-07-04 10:29
Tx date 2022-06-30
$RX
BioSyent Inc.
Federated Capital Corp.
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$194,750
+25,000 vol
$7.79 each
2,146,100
Filed 2022-07-04 10:26
Tx date 2022-06-30
$RX
BioSyent Inc.
FAX Investments Inc.
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$194,750
+25,000 vol
$7.79 each
2,146,100
Filed 2022-07-04 10:23
Tx date 2022-06-30
$RX
BioSyent Inc.
Driscoll, Blair
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$194,750
+25,000 vol
$7.79 each
2,146,100
Filed 2022-07-04 10:20
Tx date 2022-06-30
$RX
BioSyent Inc.
FAX Capital Corp.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$194,750
+25,000 vol
$7.79 each
2,146,100
Filed 2022-06-03 10:07
Tx date 2022-05-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,900 vol
0
Filed 2022-06-03 10:06
Tx date 2022-05-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,602
+200 vol
$8.01 each
1,900
Filed 2022-06-03 10:06
Tx date 2022-05-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,617
+1,700 vol
$8.01 each
1,700
Filed 2022-06-03 10:05
Tx date 2022-05-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-17,600 vol
0
Filed 2022-06-03 10:04
Tx date 2022-05-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$94,355
+11,300 vol
$8.35 each
17,600
Filed 2022-06-03 10:04
Tx date 2022-05-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$52,605
+6,300 vol
$8.35 each
6,300
Filed 2022-06-03 10:03
Tx date 2022-05-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-5,200 vol
0
Filed 2022-06-03 10:02
Tx date 2022-05-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$43,259
+5,200 vol
$8.32 each
5,200
Filed 2022-04-10 11:12
Tx date 2022-03-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$33,096
+3,641 vol
$9.09 each
66,190
Filed 2022-04-08 09:47
Tx date 2022-03-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-20,600 vol
0
Filed 2022-04-08 09:47
Tx date 2022-03-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,240
+400 vol
$8.10 each
226,100
Filed 2022-04-08 09:45
Tx date 2022-03-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,650
+200 vol
$8.25 each
20,600
Filed 2022-04-08 09:45
Tx date 2022-03-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,912
+600 vol
$8.19 each
20,400
Filed 2022-04-08 09:44
Tx date 2022-03-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$34,437
+4,200 vol
$8.20 each
19,800
Filed 2022-04-08 09:43
Tx date 2022-03-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$73,710,000
+900 vol
$81,900 each
15,600
Filed 2022-04-08 09:42
Tx date 2022-03-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,920
+600 vol
$8.20 each
14,700
Filed 2022-04-08 09:42
Tx date 2022-03-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$68,849
+8,400 vol
$8.20 each
14,100
Filed 2022-04-08 09:41
Tx date 2022-03-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,200
+1,000 vol
$8.20 each
5,700
Filed 2022-04-05 10:05
Tx date 2022-03-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$23,997
+2,640 vol
$9.09 each
15,605
Filed 2022-04-04 11:25
Tx date 2022-03-31
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$138,004
+15,182 vol
$9.09 each
966,344
Filed 2022-04-03 18:40
Tx date 2022-03-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+5,721 vol
43,424
Filed 2022-04-01 16:56
Tx date 2022-03-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$53,603
+5,897 vol
$9.09 each
44,864
Filed 2022-04-01 11:58
Tx date 2022-03-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$33,096
+3,641 vol
$9.09 each
46,658
Filed 2022-04-01 11:50
Tx date 2022-03-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$29,842
+3,283 vol
$9.09 each
14,512
Filed 2022-04-01 11:35
Tx date 2022-03-31
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+4,292 vol
170,284
Filed 2022-04-01 11:16
Tx date 2022-03-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$25,997
+2,860 vol
$9.09 each
19,924
Filed 2022-04-01 09:48
Tx date 2022-03-31
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+1,980 vol
12,550
Filed 2022-04-01 09:10
Tx date 2022-03-31
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+1,072 vol
104,635
Filed 2022-04-01 09:00
Tx date 2022-03-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-9,050
-1,000 vol
$9.05 each
17,064
Filed 2022-03-31 13:16
Tx date 2022-03-29
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-9,050
-1,000 vol
$9.05 each
18,064
Filed 2022-03-31 12:59
Tx date 2022-03-29
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-9,110.88
-999 vol
$9.12 each
7,760
Filed 2022-03-31 12:56
Tx date 2022-03-29
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-8,118.01
-901 vol
$9.01 each
8,759
Filed 2022-03-31 12:55
Tx date 2022-03-29
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-8,920
-1,000 vol
$8.92 each
9,660
Filed 2022-03-31 12:54
Tx date 2022-03-29
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-15,651.59
-1,741 vol
$8.99 each
10,660
Filed 2022-03-31 12:33
Tx date 2021-12-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,989
+1,166 vol
$7.71 each
12,965
Filed 2022-03-29 17:30
Tx date 2022-03-24
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-19,910
-2,200 vol
$9.05 each
62,549
Filed 2022-03-28 19:25
Tx date 2022-03-24
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-39,622.59
-5,193 vol
$7.63 each
11,229
Filed 2022-03-25 16:41
Tx date 2022-03-22
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-4,475
-500 vol
$8.95 each
19,564
Filed 2022-03-25 16:39
Tx date 2022-03-24
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-4,550
-500 vol
$9.10 each
19,064
Filed 2022-03-24 15:03
Tx date 2021-12-31
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,688
+1,516 vol
$7.71 each
951,162
Filed 2022-03-23 12:27
Tx date 2022-03-21
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,341.60
-607 vol
$8.80 each
16,422
Filed 2022-03-23 10:29
Tx date 2022-03-18
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-68,697.51
-8,247 vol
$8.33 each
17,029
Filed 2022-03-22 08:21
Tx date 2021-12-31
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$671.44
+88 vol
$7.63 each
103,563
Filed 2022-03-21 17:35
Tx date 2021-12-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,682
+737 vol
$7.71 each
64,749
Filed 2022-03-21 07:14
Tx date 2021-12-31
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,060
+270 vol
$7.63 each
10,580
Filed 2022-03-16 15:08
Tx date 2021-12-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+858 vol
37,703
Filed 2022-03-15 18:33
Tx date 2021-12-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$17,270
+2,240 vol
$7.71 each
38,967
Filed 2022-03-14 23:12
Tx date 2021-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,181
+672 vol
$7.71 each
25,276
Filed 2022-03-14 11:40
Tx date 2021-12-13
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,317
+560 vol
$7.71 each
20,064
Filed 2022-03-14 11:21
Tx date 2021-12-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,364
+1,474 vol
$7.71 each
43,017
Filed 2022-03-10 10:48
Tx date 2022-02-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$17,622
+2,200 vol
$8.01 each
225,700
Filed 2022-03-10 10:47
Tx date 2022-02-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,305
+4,700 vol
$8.15 each
4,700
Filed 2022-03-10 10:46
Tx date 2022-02-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-6,600 vol
0
Filed 2022-03-10 10:45
Tx date 2022-02-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-64,900 vol
6,600
Filed 2022-03-10 10:44
Tx date 2022-02-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$52,932
+6,600 vol
$8.02 each
71,500
Filed 2022-03-10 10:44
Tx date 2022-02-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$114,799
+14,000 vol
$8.20 each
64,900
Filed 2022-03-10 10:42
Tx date 2022-02-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$84,530
+10,400 vol
$8.13 each
50,900
Filed 2022-03-10 10:41
Tx date 2022-02-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,434
+3,000 vol
$8.14 each
40,500
Filed 2022-03-10 10:41
Tx date 2022-02-17
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,966
+3,800 vol
$8.15 each
37,500
Filed 2022-03-10 10:40
Tx date 2022-02-16
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,228
+1,400 vol
$8.02 each
33,700
Filed 2022-03-10 10:39
Tx date 2022-02-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,005
+500 vol
$8.01 each
32,300
Filed 2022-03-10 10:38
Tx date 2022-02-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$37,976
+4,700 vol
$8.08 each
31,800
Filed 2022-03-10 10:38
Tx date 2022-02-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,179
+1,500 vol
$8.12 each
27,100
Filed 2022-03-10 10:27
Tx date 2022-02-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$25,079
+3,100 vol
$8.09 each
25,600
Filed 2022-03-10 10:27
Tx date 2022-02-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,250
+2,500 vol
$8.10 each
22,500
Filed 2022-03-10 10:26
Tx date 2022-02-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$32,479
+4,000 vol
$8.12 each
20,000
Filed 2022-03-10 10:25
Tx date 2022-02-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,000
+1,000 vol
$8.00 each
16,000
Filed 2022-03-10 10:24
Tx date 2022-02-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,600
+1,200 vol
$8.00 each
15,000
Filed 2022-02-10 10:21
Tx date 2022-01-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$55,927
+7,000 vol
$7.99 each
223,500
Filed 2022-02-10 10:20
Tx date 2022-01-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$120,349
+15,000 vol
$8.02 each
216,500
Filed 2022-02-01 15:13
Tx date 2022-01-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-32,700 vol
13,800
Filed 2022-02-01 15:12
Tx date 2022-01-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$797.00
+100 vol
$7.97 each
46,500
Filed 2022-02-01 15:12
Tx date 2022-01-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,454
+1,700 vol
$7.91 each
46,400
Filed 2022-02-01 15:11
Tx date 2022-01-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$70,415
+8,800 vol
$8.00 each
44,700
Filed 2022-02-01 15:10
Tx date 2022-01-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,400
+2,300 vol
$8.00 each
35,900
Filed 2022-02-01 15:08
Tx date 2022-01-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,200
+900 vol
$8.00 each
33,600
Filed 2022-02-01 15:08
Tx date 2022-01-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$48,759
+6,100 vol
$7.99 each
32,700
Filed 2022-02-01 15:06
Tx date 2022-01-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$805.00
+100 vol
$8.05 each
26,600
Filed 2022-02-01 15:05
Tx date 2022-01-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,385
+4,500 vol
$8.09 each
26,500
Filed 2022-02-01 15:04
Tx date 2022-01-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,069
+2,600 vol
$8.10 each
22,000
Filed 2022-02-01 15:04
Tx date 2022-01-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$19,440
+2,400 vol
$8.10 each
19,400
Filed 2022-02-01 15:03
Tx date 2022-01-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,900
+1,200 vol
$8.25 each
17,000
Filed 2022-02-01 15:02
Tx date 2022-01-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,900
+1,200 vol
$8.25 each
15,800
Filed 2022-02-01 15:01
Tx date 2022-01-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,620
+2,500 vol
$8.25 each
14,600
Filed 2022-02-01 15:00
Tx date 2022-01-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,060
+3,000 vol
$8.02 each
12,100
Filed 2022-02-01 14:59
Tx date 2022-01-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,174
+3,000 vol
$8.06 each
9,100
Filed 2022-02-01 14:59
Tx date 2022-01-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$23,490
+2,900 vol
$8.10 each
6,100
Filed 2022-02-01 14:58
Tx date 2022-01-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$23,764
+2,900 vol
$8.19 each
3,200
Filed 2022-01-05 12:29
Tx date 2021-12-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,475
+300 vol
$8.25 each
300
Filed 2022-01-05 12:29
Tx date 2021-12-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-39,000 vol
0
Filed 2022-01-05 12:28
Tx date 2021-12-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,220
+1,000 vol
$8.22 each
39,000
Filed 2022-01-05 12:28
Tx date 2021-12-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$101,813
+12,400 vol
$8.21 each
38,000
Filed 2022-01-05 12:27
Tx date 2021-12-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$25,940
+3,200 vol
$8.11 each
25,600
Filed 2022-01-05 12:26
Tx date 2021-12-17
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$35,277
+4,200 vol
$8.40 each
22,400
Filed 2022-01-05 12:25
Tx date 2021-12-16
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,700
+200 vol
$8.50 each
18,200
Filed 2022-01-05 12:24
Tx date 2021-12-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,976
+1,800 vol
$8.32 each
18,000
Filed 2022-01-05 12:23
Tx date 2021-12-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,520
+300 vol
$8.40 each
16,200
Filed 2022-01-05 12:22
Tx date 2021-12-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$22,545
+2,700 vol
$8.35 each
15,900
Filed 2022-01-05 12:21
Tx date 2021-12-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,020
+1,200 vol
$8.35 each
13,200
Filed 2022-01-05 12:20
Tx date 2021-12-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,170
+500 vol
$8.34 each
12,000
Filed 2022-01-05 12:20
Tx date 2021-12-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$46,687
+5,600 vol
$8.34 each
11,500
Filed 2022-01-05 12:19
Tx date 2021-11-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,000
+1,000 vol
$7.00 each
5,300
Filed 2021-12-01 11:53
Tx date 2021-11-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,009
+4,300 vol
$8.37 each
4,900
Filed 2021-12-01 11:53
Tx date 2021-11-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,020
+600 vol
$8.37 each
600
Filed 2021-12-01 11:52
Tx date 2021-11-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-6,450 vol
0
Filed 2021-12-01 11:50
Tx date 2021-11-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$350.00
+50 vol
$7.00 each
6,450
Filed 2021-12-01 11:49
Tx date 2021-11-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,784
+400 vol
$6.96 each
6,400
Filed 2021-12-01 11:48
Tx date 2021-11-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,872
+700 vol
$6.96 each
6,000
Filed 2021-12-01 11:47
Tx date 2021-11-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,960
+1,000 vol
$6.96 each
5,300
Filed 2021-11-10 11:43
Tx date 2021-10-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-55,500 vol
4,300
Filed 2021-11-10 11:42
Tx date 2021-10-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,264
+900 vol
$6.96 each
59,800
Filed 2021-11-10 11:41
Tx date 2021-10-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,496
+1,400 vol
$6.78 each
58,900
Filed 2021-11-10 11:40
Tx date 2021-10-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,700
+2,000 vol
$6.85 each
57,500
Filed 2021-11-10 11:39
Tx date 2021-10-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$17,172
+2,500 vol
$6.87 each
55,500
Filed 2021-11-10 11:38
Tx date 2021-10-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,620
+4,400 vol
$6.96 each
53,000
Filed 2021-11-10 11:37
Tx date 2021-10-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$17,250
+2,500 vol
$6.90 each
48,600
Filed 2021-11-10 11:36
Tx date 2021-10-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$40,695
+5,900 vol
$6.90 each
46,100
Filed 2021-11-10 11:36
Tx date 2021-10-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,236
+900 vol
$6.93 each
40,200
Filed 2021-11-10 11:35
Tx date 2021-10-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$158,716
+22,700 vol
$6.99 each
39,300
Filed 2021-11-10 11:34
Tx date 2021-10-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,893
+700 vol
$6.99 each
16,600
Filed 2021-11-10 11:33
Tx date 2021-10-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$37,077
+5,300 vol
$7.00 each
15,900
Filed 2021-11-10 11:33
Tx date 2021-10-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,100
+4,300 vol
$7.00 each
10,600
Filed 2021-11-10 11:32
Tx date 2021-10-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,200
+2,600 vol
$7.00 each
6,300
Filed 2021-11-10 11:31
Tx date 2021-10-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,700
+2,100 vol
$7.00 each
3,700
Filed 2021-11-10 11:31
Tx date 2021-10-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,800
+400 vol
$7.00 each
1,600
Filed 2021-11-10 11:30
Tx date 2021-10-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,600
+800 vol
$7.00 each
1,200
Filed 2021-11-10 11:29
Tx date 2021-10-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,800
+400 vol
$7.00 each
400
Filed 2021-10-08 09:32
Tx date 2021-09-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-5,200 vol
0
Filed 2021-10-08 09:31
Tx date 2021-09-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,395
+5,200 vol
$7.00 each
5,200
Filed 2021-09-10 08:37
Tx date 2021-08-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$50,317
+6,700 vol
$7.51 each
201,500
Filed 2021-08-09 17:03
Tx date 2021-07-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$24,783
+3,300 vol
$7.51 each
194,800
Filed 2021-08-09 17:02
Tx date 2021-07-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$76,600
+10,000 vol
$7.66 each
191,500
Filed 2021-08-09 17:01
Tx date 2021-07-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$155,200
+20,000 vol
$7.76 each
181,500
Filed 2021-07-08 13:53
Tx date 2021-06-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$2,985
+400 vol
$7.46 each
161,500
Filed 2021-06-11 11:37
Tx date 2021-06-09
$RX
BioSyent Inc.
Driscoll, Merrilyn Joy
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
2,121,100
Filed 2021-06-11 11:31
Tx date 2021-06-09
$RX
BioSyent Inc.
Driscoll, Sean
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
2,121,100
Filed 2021-06-11 11:28
Tx date 2021-06-09
$RX
BioSyent Inc.
Driscoll, Blair
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
2,121,100
Filed 2021-06-11 11:24
Tx date 2021-06-09
$RX
BioSyent Inc.
Federated Capital Corp.
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
2,121,100
Filed 2021-06-11 11:18
Tx date 2021-06-09
$RX
BioSyent Inc.
FAX Investments Inc.
3 - 10% Security Holder of Issuer
Holder: FAX Capital Corp. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
2,121,100
Filed 2021-06-11 11:09
Tx date 2021-06-09
$RX
BioSyent Inc.
FAX Capital Corp.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,121,100
Filed 2021-05-07 08:53
Tx date 2021-04-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$28,860
+3,900 vol
$7.40 each
161,100
Filed 2021-04-09 09:19
Tx date 2021-03-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$186,250
+25,000 vol
$7.45 each
157,200
Filed 2021-04-09 09:17
Tx date 2021-03-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-9,500 vol
0
Filed 2021-04-09 09:16
Tx date 2021-03-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-65,000 vol
9,500
Filed 2021-04-09 09:16
Tx date 2021-03-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$66,975
+9,500 vol
$7.05 each
74,500
Filed 2021-04-09 09:15
Tx date 2021-03-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$458,250
+65,000 vol
$7.05 each
65,000
Filed 2021-03-24 17:28
Tx date 2021-03-19
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$131,998
+18,082 vol
$7.30 each
949,646
Filed 2021-03-24 17:26
Tx date 2020-12-31
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,357
+1,063 vol
$5.04 each
931,564
Filed 2021-03-23 17:20
Tx date 2021-03-19
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$29,236
+4,005 vol
$7.30 each
24,604
Filed 2021-03-23 13:51
Tx date 2021-03-19
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+1,224 vol
103,475
Filed 2021-03-23 12:28
Tx date 2021-03-19
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$20,301
+2,781 vol
$7.30 each
11,799
Filed 2021-03-23 08:50
Tx date 2021-03-19
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$52,005
+7,124 vol
$7.30 each
36,727
Filed 2021-03-22 10:19
Tx date 2021-03-19
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$32,083
+4,395 vol
$7.30 each
64,012
Filed 2021-03-20 12:51
Tx date 2021-03-19
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+4,897 vol
165,992
Filed 2021-03-19 19:50
Tx date 2021-03-19
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$32,083
+4,395 vol
$7.30 each
41,543
Filed 2021-03-19 18:27
Tx date 2021-03-19
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+2,260 vol
10,570
Filed 2021-03-19 17:30
Tx date 2021-03-19
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+6,825 vol
36,845
Filed 2021-03-19 16:44
Tx date 2021-03-19
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$24,360
+3,337 vol
$7.30 each
19,504
Filed 2021-03-12 13:50
Tx date 2020-12-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,952
+412 vol
$4.74 each
9,018
Filed 2021-03-12 06:46
Tx date 2020-12-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,615
+519 vol
$5.04 each
59,617
Filed 2021-03-11 17:05
Tx date 2020-12-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,600
+516 vol
$5.04 each
37,148
Filed 2021-03-11 14:48
Tx date 2020-12-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,607
+950 vol
$4.85 each
29,603
Filed 2021-03-10 22:52
Tx date 2020-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,383
+473 vol
$5.04 each
20,599
Filed 2021-03-10 22:46
Tx date 2020-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,383
+473 vol
$5.04 each
Filed 2021-03-10 17:12
Tx date 2020-12-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+601 vol
30,020
Filed 2021-03-10 16:13
Tx date 2020-12-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,980
+393 vol
$5.04 each
16,167
Filed 2021-01-08 10:34
Tx date 2020-12-16
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$5,715
+800 vol
$7.14 each
132,200
Filed 2021-01-08 10:33
Tx date 2020-12-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$24,140
+3,400 vol
$7.10 each
131,400
Filed 2020-06-26 16:35
Tx date 2020-06-24
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+1,000 vol
29,419
Filed 2020-06-08 10:23
Tx date 2020-06-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-52,400 vol
0
Filed 2020-06-08 10:22
Tx date 2020-06-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,000 vol
52,400
Filed 2020-06-08 10:22
Tx date 2020-05-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$209,076
+52,400 vol
$3.99 each
53,400
Filed 2020-06-08 10:21
Tx date 2020-05-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,990
+1,000 vol
$3.99 each
1,000
Filed 2020-06-08 10:20
Tx date 2020-05-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-18,000 vol
0
Filed 2020-06-08 10:19
Tx date 2020-05-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-109,600 vol
18,000
Filed 2020-06-08 10:19
Tx date 2020-05-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$47,880
+12,000 vol
$3.99 each
127,600
Filed 2020-06-08 10:18
Tx date 2020-05-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$23,940
+6,000 vol
$3.99 each
115,600
Filed 2020-06-08 10:17
Tx date 2020-05-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$437,304
+109,600 vol
$3.99 each
109,600
Filed 2020-06-08 10:16
Tx date 2020-05-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-9,500 vol
0
Filed 2020-05-08 09:30
Tx date 2020-05-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-67,000 vol
9,500
Filed 2020-05-08 09:30
Tx date 2020-04-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$798.00
+200 vol
$3.99 each
76,500
Filed 2020-05-08 09:29
Tx date 2020-04-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$37,107
+9,300 vol
$3.99 each
76,300
Filed 2020-05-08 09:28
Tx date 2020-04-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$267,330
+67,000 vol
$3.99 each
67,000
Filed 2020-05-08 09:26
Tx date 2020-04-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-2,900 vol
0
Filed 2020-05-08 09:26
Tx date 2020-04-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,583
+700 vol
$3.69 each
2,900
Filed 2020-05-08 09:25
Tx date 2020-04-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,118
+2,200 vol
$3.69 each
2,200
Filed 2020-05-08 09:24
Tx date 2020-04-17
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-36,000 vol
0
Filed 2020-05-08 09:23
Tx date 2020-04-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,210
+9,000 vol
$3.69 each
36,000
Filed 2020-05-08 09:22
Tx date 2020-04-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,210
+9,000 vol
$3.69 each
27,000
Filed 2020-05-08 09:22
Tx date 2020-04-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-36,000 vol
18,000
Filed 2020-05-08 09:21
Tx date 2020-04-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,210
+9,000 vol
$3.69 each
54,000
Filed 2020-05-08 09:20
Tx date 2020-04-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,210
+9,000 vol
$3.69 each
45,000
Filed 2020-05-08 09:19
Tx date 2020-04-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,210
+9,000 vol
$3.69 each
36,000
Filed 2020-05-08 09:19
Tx date 2020-04-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,210
+9,000 vol
$3.69 each
27,000
Filed 2020-05-08 09:18
Tx date 2020-04-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,210
+9,000 vol
$3.69 each
18,000
Filed 2020-05-08 09:17
Tx date 2020-04-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$32,987
+9,000 vol
$3.67 each
149,175
Filed 2020-04-06 15:18
Tx date 2020-03-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$216,000
+60,000 vol
$3.60 each
128,000
Filed 2020-04-06 15:17
Tx date 2020-03-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$71,994
+20,000 vol
$3.60 each
68,000
Filed 2020-04-06 15:15
Tx date 2020-03-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$71,432
+20,000 vol
$3.57 each
48,000
Filed 2020-04-06 15:14
Tx date 2020-03-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$57,745
+16,000 vol
$3.61 each
28,000
Filed 2020-04-06 15:13
Tx date 2020-03-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$42,723
+12,000 vol
$3.56 each
12,000
Filed 2020-04-06 15:10
Tx date 2018-12-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-04-06 15:00
Tx date 2020-04-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-140,175 vol
0
Filed 2020-04-06 14:59
Tx date 2020-03-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$291,628
+80,175 vol
$3.64 each
140,175
Filed 2020-04-06 14:58
Tx date 2020-03-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$216,000
+60,000 vol
$3.60 each
60,000
Filed 2020-04-06 14:57
Tx date 2020-03-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-34,000 vol
0
Filed 2020-04-06 14:56
Tx date 2020-03-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$173,060
+34,000 vol
$5.09 each
34,000
Filed 2020-04-05 22:05
Tx date 2020-03-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+6,981 vol
20,126
Filed 2020-04-05 09:34
Tx date 2020-03-31
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$29,999
+8,310 vol
$3.61 each
10,310
Filed 2020-04-03 10:27
Tx date 2020-03-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+11,891 vol
28,419
Filed 2020-04-03 08:45
Tx date 2020-03-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+12,408 vol
28,653
Filed 2020-04-03 08:34
Tx date 2020-03-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$27,648
+7,659 vol
$3.61 each
59,098
Filed 2020-04-02 12:58
Tx date 2020-03-31
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$113,751
+31,510 vol
$3.61 each
930,501
Filed 2020-04-02 12:30
Tx date 2020-03-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$20,999
+5,817 vol
$3.61 each
15,774
Filed 2020-04-02 12:23
Tx date 2020-03-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$27,648
+7,659 vol
$3.61 each
36,632
Filed 2020-04-02 11:39
Tx date 2020-03-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$17,501
+4,848 vol
$3.61 each
8,606
Filed 2020-04-01 10:17
Tx date 2020-03-31
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
$29,999
+8,310 vol
$3.61 each
8,310
Filed 2020-04-01 10:13
Tx date 2018-01-08
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2020-04-01 09:55
Tx date 2020-03-31
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+9,003 vol
161,095
Filed 2020-04-01 09:49
Tx date 2020-03-31
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+2,251 vol
102,251
Filed 2020-03-31 18:26
Tx date 2020-03-31
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,400
+4,000 vol
$3.60 each
898,991
Filed 2020-03-31 18:21
Tx date 2020-03-31
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$15,495
+2,114 vol
$7.33 each
894,991
Filed 2020-03-31 15:52
Tx date 2019-12-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,697
+640 vol
$7.34 each
3,758
Filed 2020-03-31 15:48
Tx date 2019-03-19
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
3,118
Filed 2020-03-31 12:17
Tx date 2020-03-30
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,400
+4,000 vol
$3.60 each
16,528
Filed 2020-03-31 11:43
Tx date 2020-03-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,696
+1,050 vol
$7.33 each
51,439
Filed 2020-03-24 11:19
Tx date 2020-03-23
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$63,525
+18,150 vol
$3.50 each
28,973
Filed 2020-03-23 09:39
Tx date 2019-03-19
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$39,250
+4,775 vol
$8.22 each
10,649
Filed 2020-03-23 09:31
Tx date 2020-03-20
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,925
+2,500 vol
$3.57 each
16,245
Filed 2019-03-22 15:21
Tx date 2019-03-19
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$39,250
+4,775 vol
$8.22 each
Filed 2020-03-13 14:17
Tx date 2019-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,188
+1,278 vol
$7.19 each
13,145
Filed 2020-03-02 12:47
Tx date 2019-12-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,860
+1,037 vol
$7.58 each
12,528
Filed 2020-03-02 10:53
Tx date 2019-12-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,501
+1,022 vol
$7.34 each
10,823
Filed 2020-03-02 10:14
Tx date 2020-01-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,422
+1,552 vol
$7.36 each
18,520
Filed 2020-03-02 08:42
Tx date 2019-12-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,746
+784 vol
$7.33 each
9,957
Filed 2020-02-10 10:54
Tx date 2020-01-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-38,300 vol
0
Filed 2020-02-10 10:54
Tx date 2020-01-21
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$229,800
+38,300 vol
$6.00 each
38,300
Filed 2020-02-10 10:52
Tx date 2020-01-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-5,000 vol
0
Filed 2020-02-10 10:52
Tx date 2020-01-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$19,800
+3,300 vol
$6.00 each
5,000
Filed 2020-02-10 10:51
Tx date 2020-01-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,200
+1,700 vol
$6.00 each
1,700
Filed 2020-01-10 10:23
Tx date 2020-01-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-30,000 vol
0
Filed 2020-01-10 10:22
Tx date 2019-12-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$29,750
+5,000 vol
$5.95 each
30,000
Filed 2020-01-10 10:21
Tx date 2019-12-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$123,499
+20,600 vol
$6.00 each
25,000
Filed 2020-01-10 10:20
Tx date 2019-12-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$26,400
+4,400 vol
$6.00 each
4,400
Filed 2020-01-10 10:19
Tx date 2019-12-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-21,000 vol
0
Filed 2020-01-10 10:18
Tx date 2019-12-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,980
+1,000 vol
$5.98 each
21,000
Filed 2020-01-10 10:17
Tx date 2019-12-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$120,000
+20,000 vol
$6.00 each
20,000
Filed 2019-12-24 18:41
Tx date 2002-06-25
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: AQUIAM (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2019-12-22 09:13
Tx date 2019-12-18
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+200 vol
11,491
Filed 2019-11-08 15:49
Tx date 2019-10-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-47,177 vol
0
Filed 2019-11-08 15:49
Tx date 2019-10-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$291,406
+47,077 vol
$6.19 each
47,177
Filed 2019-11-08 15:48
Tx date 2019-10-15
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-17,323 vol
100
Filed 2019-11-08 15:47
Tx date 2019-10-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$619.00
+100 vol
$6.19 each
17,423
Filed 2019-11-08 15:47
Tx date 2019-10-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,400
+400 vol
$6.00 each
17,323
Filed 2019-11-08 15:46
Tx date 2019-10-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-23,500 vol
16,923
Filed 2019-11-08 15:45
Tx date 2019-10-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,230
+16,923 vol
$6.10 each
40,423
Filed 2019-11-08 15:44
Tx date 2019-10-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$15,600
+2,600 vol
$6.00 each
23,500
Filed 2019-10-10 13:39
Tx date 2019-09-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-47,500 vol
20,900
Filed 2019-10-10 13:38
Tx date 2019-09-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$54,000
+9,000 vol
$6.00 each
68,400
Filed 2019-10-10 13:36
Tx date 2019-09-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,200
+200 vol
$6.00 each
59,400
Filed 2019-10-10 13:36
Tx date 2019-09-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$69,523
+11,600 vol
$5.99 each
59,200
Filed 2019-10-10 13:35
Tx date 2019-09-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$595.00
+100 vol
$5.95 each
47,600
Filed 2019-10-10 13:34
Tx date 2019-09-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$54,701
+9,100 vol
$6.01 each
47,500
Filed 2019-10-10 13:34
Tx date 2019-09-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-55,900 vol
38,400
Filed 2019-10-10 13:33
Tx date 2019-09-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$89,528
+14,800 vol
$6.05 each
94,300
Filed 2019-10-10 13:32
Tx date 2019-09-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$75,726
+12,600 vol
$6.01 each
79,500
Filed 2019-10-10 13:31
Tx date 2019-09-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$66,155
+11,000 vol
$6.01 each
66,900
Filed 2019-10-10 13:30
Tx date 2019-09-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$40,267
+6,700 vol
$6.01 each
55,900
Filed 2019-10-10 13:26
Tx date 2019-09-17
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$204,076
+32,600 vol
$6.26 each
49,200
Filed 2019-10-10 13:25
Tx date 2019-09-16
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$85,956
+13,800 vol
$6.23 each
16,600
Filed 2019-10-10 13:21
Tx date 2019-09-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,845
+300 vol
$6.15 each
2,800
Filed 2019-10-10 13:21
Tx date 2019-09-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-2,500 vol
2,500
Filed 2019-10-10 13:20
Tx date 2019-09-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,594
+600 vol
$5.99 each
5,000
Filed 2019-10-10 13:19
Tx date 2019-09-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-7,400 vol
4,400
Filed 2019-10-10 13:17
Tx date 2019-09-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,785
+300 vol
$5.95 each
11,800
Filed 2019-10-10 13:17
Tx date 2019-09-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,440
+1,600 vol
$5.90 each
11,500
Filed 2019-10-10 13:16
Tx date 2019-09-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,630
+2,500 vol
$5.85 each
9,900
Filed 2019-10-10 13:15
Tx date 2019-09-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,645
+3,700 vol
$5.85 each
7,400
Filed 2019-09-10 09:50
Tx date 2019-08-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,805
+2,200 vol
$5.82 each
3,700
Filed 2019-09-10 09:49
Tx date 2019-08-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-31,932 vol
1,500
Filed 2019-09-10 09:48
Tx date 2019-08-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,700
+1,500 vol
$5.80 each
33,432
Filed 2019-09-10 09:47
Tx date 2019-08-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,509
+432 vol
$5.81 each
31,932
Filed 2019-09-10 09:46
Tx date 2019-08-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$34,742
+5,800 vol
$5.99 each
31,500
Filed 2019-09-10 09:45
Tx date 2019-08-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,032
+5,100 vol
$5.89 each
25,700
Filed 2019-09-10 09:43
Tx date 2019-08-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-700 vol
20,600
Filed 2019-09-10 09:42
Tx date 2019-08-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$118,392
+20,600 vol
$5.75 each
21,300
Filed 2019-09-10 09:41
Tx date 2019-08-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-800 vol
700
Filed 2019-09-10 09:40
Tx date 2019-08-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,774
+600 vol
$6.29 each
1,500
Filed 2019-09-10 09:39
Tx date 2019-08-16
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$629.00
+100 vol
$6.29 each
900
Filed 2019-09-10 09:38
Tx date 2019-08-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,024
+800 vol
$6.28 each
800
Filed 2019-08-09 10:21
Tx date 2019-07-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-4,500 vol
0
Filed 2019-08-09 10:20
Tx date 2019-07-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,305
+4,500 vol
$6.29 each
4,500
Filed 2019-07-10 09:50
Tx date 2019-07-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-15,000 vol
0
Filed 2019-07-10 09:49
Tx date 2019-06-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$97,500
+15,000 vol
$6.50 each
15,000
Filed 2019-07-10 09:46
Tx date 2019-06-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-262,100 vol
0
Filed 2019-07-10 09:45
Tx date 2019-06-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,884,499
+262,100 vol
$7.19 each
262,100
Filed 2019-06-24 16:14
Tx date 2019-06-24
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,980
+300 vol
$6.60 each
14,100
Filed 2019-06-17 17:47
Tx date 2019-06-17
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,350
+200 vol
$6.75 each
13,800
Filed 2019-06-07 10:10
Tx date 2019-05-17
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-9,200 vol
0
Filed 2019-06-07 10:09
Tx date 2019-05-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,250
+1,500 vol
$7.50 each
9,200
Filed 2019-06-07 10:09
Tx date 2019-05-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-11,700 vol
7,700
Filed 2019-06-07 10:07
Tx date 2019-05-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,500
+600 vol
$7.50 each
19,400
Filed 2019-06-07 10:06
Tx date 2019-05-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$53,250
+7,100 vol
$7.50 each
18,800
Filed 2019-06-07 10:06
Tx date 2019-05-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$42,000
+5,600 vol
$7.50 each
11,700
Filed 2019-06-07 10:05
Tx date 2019-05-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,250
+5,100 vol
$7.50 each
6,100
Filed 2019-06-07 10:04
Tx date 2019-05-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,400
+1,000 vol
$7.40 each
46,800
Filed 2019-06-03 17:21
Tx date 2019-06-03
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,700
+400 vol
$6.75 each
13,600
Filed 2019-05-14 10:24
Tx date 2019-04-26
$RX
BioSyent Inc.
D'Souza, Alfred
4 - Director of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-300,000
-40,000 vol
$7.50 each
1,386,300
Filed 2019-05-10 09:49
Tx date 2019-05-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-45,800 vol
0
Filed 2019-05-10 09:48
Tx date 2019-04-30
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,100
+1,500 vol
$7.40 each
45,800
Filed 2019-05-10 09:47
Tx date 2019-04-29
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$23,680
+3,200 vol
$7.40 each
44,300
Filed 2019-05-10 09:45
Tx date 2019-04-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$300,000
+40,000 vol
$7.50 each
41,100
Filed 2019-05-10 09:44
Tx date 2019-04-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-51,000 vol
1,100
Filed 2019-05-10 09:42
Tx date 2019-04-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,195
+1,100 vol
$7.45 each
52,100
Filed 2019-05-10 09:41
Tx date 2019-04-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$190,686
+25,500 vol
$7.48 each
51,000
Filed 2019-05-10 09:40
Tx date 2019-04-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$185,504
+24,800 vol
$7.48 each
25,500
Filed 2019-05-10 09:39
Tx date 2019-04-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-2,900 vol
700
Filed 2019-05-10 09:37
Tx date 2019-04-16
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,236
+700 vol
$7.48 each
3,600
Filed 2019-05-10 09:36
Tx date 2019-04-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,750
+500 vol
$7.50 each
2,900
Filed 2019-05-10 09:35
Tx date 2019-04-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,496
+200 vol
$7.48 each
2,400
Filed 2019-05-10 09:35
Tx date 2019-04-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,410
+1,800 vol
$7.45 each
2,200
Filed 2019-05-10 09:33
Tx date 2019-04-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,980
+400 vol
$7.45 each
400
Filed 2019-04-10 10:09
Tx date 2019-04-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-50,000 vol
0
Filed 2019-04-10 10:07
Tx date 2019-04-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-115,200 vol
50,000
Filed 2019-04-10 10:06
Tx date 2019-03-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$186,250
+25,000 vol
$7.45 each
165,200
Filed 2019-04-10 10:03
Tx date 2019-03-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$187,500
+25,000 vol
$7.50 each
140,200
Filed 2019-04-10 10:02
Tx date 2019-03-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$184,500
+24,600 vol
$7.50 each
115,200
Filed 2019-04-10 10:01
Tx date 2019-03-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$298,302
+40,500 vol
$7.37 each
90,600
Filed 2019-04-10 09:59
Tx date 2019-03-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$400,000
+50,000 vol
$8.00 each
50,100
Filed 2019-04-10 09:57
Tx date 2019-02-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$800.00
+100 vol
$8.00 each
100
Filed 2019-03-28
Tx date 2019-03-19
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$15,371
+1,870 vol
$8.22 each
1,870
Filed 2019-03-28
Tx date 2019-03-28
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$85,021
+11,291 vol
$7.53 each
11,291
Filed 2019-03-28
Tx date 2019-03-25
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,340
+1,000 vol
$7.34 each
Filed 2019-03-28
Tx date 2019-03-25
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,680
+2,000 vol
$7.34 each
2,000
Filed 2019-03-28
Tx date 2019-03-19
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-28
Tx date 2018-09-04
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-28
Tx date 2019-03-28
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$90,021
+11,955 vol
$7.53 each
16,968
Filed 2019-03-28
Tx date 2018-01-08
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-27
Tx date 2018-12-31
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$15,000
+1,574 vol
$9.53 each
892,877
Filed 2019-03-24
Tx date 2019-03-19
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$25,186
+3,064 vol
$8.22 each
19,951
Filed 2019-03-24
Tx date 2019-03-19
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$98,113
+11,936 vol
$8.22 each
334,345
Filed 2019-03-22
Tx date 2019-03-19
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$22,892
+2,785 vol
$8.22 each
12,401
Filed 2019-03-22
Tx date 2019-03-19
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$37,063
+4,509 vol
$8.22 each
9,948
Filed 2019-03-22
Tx date 2019-03-19
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$39,250
+4,775 vol
$8.22 each
5,013
Filed 2019-03-22
Tx date 2019-03-19
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$18,807
+2,288 vol
$8.22 each
9,173
Filed 2019-03-22
Tx date 2019-03-19
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$24,528
+2,984 vol
$8.22 each
15,184
Filed 2019-03-11
Tx date 2018-12-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,602
+586 vol
$9.56 each
6,885
Filed 2019-03-08
Tx date 2019-02-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-5,300 vol
0
Filed 2019-03-08
Tx date 2019-02-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,200
+3,400 vol
$8.00 each
5,300
Filed 2019-03-08
Tx date 2019-02-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$15,200
+1,900 vol
$8.00 each
1,900
Filed 2019-03-07
Tx date 2018-09-10
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
238
Filed 2019-03-07
Tx date 2018-09-10
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-06
Tx date 2019-03-05
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,500
+787 vol
$9.53 each
50,389
Filed 2019-03-04
Tx date 2018-12-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,147
+750 vol
$9.53 each
9,801
Filed 2019-03-04
Tx date 2018-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$16,945
+1,780 vol
$9.52 each
11,867
Filed 2019-02-08
Tx date 2019-01-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$190,400
+23,800 vol
$8.00 each
50,400
Filed 2019-02-08
Tx date 2019-01-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-23,800 vol
0
Filed 2019-02-08
Tx date 2019-01-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$212,440
+26,600 vol
$7.99 each
26,600
Filed 2019-02-08
Tx date 2019-01-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-20,068 vol
0
Filed 2019-02-08
Tx date 2019-01-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-26,600 vol
23,800
Filed 2019-02-03
Tx date 2019-01-30
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-190,021
-23,500 vol
$8.09 each
1,426,300
Filed 2019-01-21
Tx date 2019-01-15
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-212,000
-26,500 vol
$8.00 each
1,449,800
Filed 2019-01-03
Tx date 2018-12-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-14,500 vol
20,068
Filed 2019-01-03
Tx date 2018-12-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-57,600 vol
16,200
Filed 2019-01-03
Tx date 2018-12-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,260
+1,700 vol
$7.80 each
73,800
Filed 2019-01-03
Tx date 2018-12-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-01-03
Tx date 2018-12-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,400
+3,800 vol
$8.00 each
20,100
Filed 2019-01-03
Tx date 2018-12-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,166
+3,400 vol
$7.99 each
57,600
Filed 2019-01-03
Tx date 2018-12-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$780.00
+100 vol
$7.80 each
16,300
Filed 2019-01-03
Tx date 2018-12-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$433,594
+54,200 vol
$8.00 each
54,200
Filed 2019-01-03
Tx date 2018-12-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$44,800
+5,600 vol
$8.00 each
63,200
Filed 2019-01-03
Tx date 2018-12-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$115,744
+14,468 vol
$8.00 each
34,568
Filed 2019-01-03
Tx date 2018-12-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$71,200
+8,900 vol
$8.00 each
72,100
Filed 2018-12-21
Tx date 2018-12-21
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$37,268
+8,375 vol
$4.45 each
330,784
Filed 2018-12-21
Tx date 2018-12-21
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
10 - Acquisition or disposition in the public market
$-64,545
-8,275 vol
$7.80 each
322,509
Filed 2018-12-21
Tx date 2018-12-21
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
10 - Acquisition or disposition in the public market
$-781.00
-100 vol
$7.81 each
322,409
Filed 2018-12-14
Tx date 2018-12-14
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,000
-500 vol
$8.00 each
152,092
Filed 2018-12-14
Tx date 2018-12-14
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Carson RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-21,600
-2,700 vol
$8.00 each
0
Filed 2018-12-14
Tx date 2018-12-14
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-4,800
-600 vol
$8.00 each
0
Filed 2018-11-15
Tx date 2018-11-12
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$-12,985
-1,400 vol
$9.28 each
1,476,300
Filed 2018-11-03
Tx date 2018-11-02
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-130,690
-14,000 vol
$9.34 each
1,477,700
Filed 2018-11-03
Tx date 2018-10-29
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-6,545
-700 vol
$9.35 each
1,491,700
Filed 2018-10-04
Tx date 2018-10-01
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$-9,705.60
-1,011 vol
$9.60 each
Filed 2018-10-04
Tx date 2018-09-27
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$-9,705.60
-1,011 vol
$9.60 each
Filed 2018-10-04
Tx date 2018-09-27
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$6,901
+1,551 vol
$4.45 each
16,887
Filed 2018-10-04
Tx date 2018-09-27
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-9,705.60
-1,011 vol
$9.60 each
49,602
Filed 2018-10-02
Tx date 2018-10-01
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$-9,705.60
-1,011 vol
$9.60 each
49,602
Filed 2018-09-19
Tx date 2018-09-07
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-133,700
-14,000 vol
$9.55 each
1,492,400
Filed 2018-09-13
Tx date 2018-09-10
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
5,874
Filed 2018-09-12
Tx date 2018-09-10
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-392,179.20
-40,852 vol
$9.60 each
927,303
Filed 2018-09-12
Tx date 2018-09-12
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-345,600
-36,000 vol
$9.60 each
891,303
Filed 2018-09-12
Tx date 2018-09-10
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,825
-500 vol
$9.65 each
968,155
Filed 2018-09-12
Tx date 2018-09-07
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-169,035
-17,700 vol
$9.55 each
968,655
Filed 2018-09-11
Tx date 2018-09-10
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$52,214
+5,439 vol
$9.60 each
5,439
Filed 2018-09-11
Tx date 2018-09-04
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-01
Tx date 2018-08-27
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-462,500
-50,000 vol
$9.25 each
1,506,400
Filed 2018-07-01
Tx date 2018-06-29
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-6,636
-700 vol
$9.48 each
1,556,400
Filed 2018-07-01
Tx date 2018-06-25
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-95,000
-10,000 vol
$9.50 each
1,557,100
Filed 2018-06-27
Tx date 2018-06-25
$RX
BioSyent Inc.
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-25,137
-2,646 vol
$9.50 each
1,407
Filed 2018-06-27
Tx date 2018-06-25
$RX
BioSyent Inc.
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$18,035
+4,053 vol
$4.45 each
4,053
Filed 2018-06-27
Tx date 2018-06-25
$RX
BioSyent Inc.
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$6,261
+1,407 vol
$4.45 each
Filed 2018-06-26
Tx date 2018-06-25
$RX
BioSyent Inc.
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-18,035.85
-4,053 vol
$4.45 each
4,165
Filed 2018-06-26
Tx date 2018-06-25
$RX
BioSyent Inc.
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$6,261
+1,407 vol
$4.45 each
1,407
Filed 2018-06-26
Tx date 2014-01-15
$RX
BioSyent Inc.
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-06-19
Tx date 2018-06-13
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-14,685
-3,300 vol
$4.45 each
14,627
Filed 2018-06-19
Tx date 2018-06-18
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-982.00
-100 vol
$9.82 each
1,567,100
Filed 2018-06-19
Tx date 2018-06-15
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-16,745
-1,700 vol
$9.85 each
1,567,200
Filed 2018-06-19
Tx date 2018-06-13
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-29,610
-3,000 vol
$9.87 each
1,568,900
Filed 2018-06-19
Tx date 2018-06-13
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$-33,000
-3,300 vol
$10.00 each
2,371
Filed 2018-06-19
Tx date 2018-06-13
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$14,685
+3,300 vol
$4.45 each
5,671
Filed 2018-06-12
Tx date 2018-06-08
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-20,060
-2,000 vol
$10.03 each
1,571,900
Filed 2018-06-12
Tx date 2018-06-06
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-21,105
-2,100 vol
$10.05 each
1,573,900
Filed 2018-06-01
Tx date 2003-10-21
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-06-01
Tx date 2018-01-08
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$10,905
+1,136 vol
$9.60 each
1,136
Filed 2018-06-01
Tx date 2018-05-29
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$31,012
+3,120 vol
$9.94 each
4,256
Filed 2018-06-01
Tx date 2018-06-01
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,920
+400 vol
$9.80 each
152,592
Filed 2018-03-28
Tx date 2017-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$16,495
+1,841 vol
$8.96 each
10,087
Filed 2018-03-28
Tx date 2017-12-31
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$21,244
+2,371 vol
$8.96 each
2,371
Filed 2018-03-27
Tx date 2017-12-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,096
+792 vol
$8.96 each
50,613
Filed 2018-03-27
Tx date 2017-12-31
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$13,995
+1,562 vol
$8.96 each
986,355
Filed 2018-03-26
Tx date 2017-12-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,001
+302 vol
$9.94 each
6,299
Filed 2018-03-26
Tx date 2017-12-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,648
+742 vol
$8.96 each
9,051
Filed 2018-01-15
Tx date 2018-01-08
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$38,419
+4,002 vol
$9.60 each
17,927
Filed 2018-01-12
Tx date 2018-01-08
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$93,456
+9,735 vol
$9.60 each
322,409
Filed 2018-01-12
Tx date 2018-01-08
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$21,100
+2,198 vol
$9.60 each
9,616
Filed 2018-01-11
Tx date 2018-01-08
$RX
BioSyent Inc.
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$24,921
+2,596 vol
$9.60 each
8,517
Filed 2018-01-11
Tx date 2018-01-08
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$17,443
+1,817 vol
$9.60 each
5,702
Filed 2018-01-11
Tx date 2018-01-08
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$22,272
+2,320 vol
$9.60 each
12,200
Filed 2018-01-11
Tx date 2018-01-08
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$31,152
+3,245 vol
$9.60 each
3,245
Filed 2018-01-11
Tx date 2018-01-08
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-11
Tx date 2018-01-08
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-09
Tx date 2018-01-09
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$23,366
+2,434 vol
$9.60 each
15,336
Filed 2018-01-09
Tx date 2018-01-08
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$10,905
+1,136 vol
$9.60 each
49,058
Filed 2018-01-09
Tx date 2018-01-08
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
3,245
Filed 2018-01-09
Tx date 2018-01-08
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
13,200
Filed 2018-01-09
Tx date 2018-01-08
$RX
BioSyent Inc.
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$10,905
+1,136 vol
$9.60 each
8,218
Filed 2018-01-08
Tx date 1996-06-07
$RX
Hedley Technologies Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2018-01-08
Tx date 1996-07-25
$RX
Hedley Technologies Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-08
Tx date 1996-07-25
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-08
Tx date 1996-06-07
$RX
Hedley Technologies Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
65,000
Filed 2018-01-08
Tx date 1996-06-07
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
250,000
Filed 2018-01-08
Tx date 1996-07-25
$RX
Hedley Technologies Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-08
Tx date 1996-06-07
$RX
Hedley Technologies Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Warrants
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2018-01-08
Tx date 1996-07-25
$RX
Hedley Technologies Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-12-23
Tx date 2017-12-18
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$8,918
+9,800 vol
$0.91 each
312,674
Filed 2017-12-23
Tx date 2017-12-18
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$96,725
+9,800 vol
$9.87 each
984,793
Filed 2017-12-18
Tx date 2017-12-15
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$-14,076.70
-1,474 vol
$9.55 each
49,821
Filed 2017-12-05
Tx date 2017-12-05
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-5,100
-500 vol
$10.20 each
600
Filed 2017-12-04
Tx date 2017-12-01
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,400
-800 vol
$10.50 each
277,900
Filed 2017-12-04
Tx date 2017-12-04
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-5,150
-500 vol
$10.30 each
1,100
Filed 2017-12-04
Tx date 2017-12-04
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-5,150
-500 vol
$10.30 each
1,600
Filed 2017-11-24
Tx date 2017-11-24
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-5,125
-500 vol
$10.25 each
2,100
Filed 2017-11-23
Tx date 2017-11-20
$RX
BioSyent Inc.
Montador, Paul
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$3,549
+3,900 vol
$0.91 each
11,822
Filed 2017-11-23
Tx date 2017-11-20
$RX
BioSyent Inc.
Montador, Paul
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$39,780
+3,900 vol
$10.20 each
78,900
Filed 2017-11-23
Tx date 2017-11-23
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-5,100
-500 vol
$10.20 each
2,600
Filed 2017-09-26
Tx date 2017-09-21
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
51 - Exercise of options
$5,551
+6,100 vol
$0.91 each
1,582,100
Filed 2017-09-26
Tx date 2017-09-21
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-5,551
-6,100 vol
$0.91 each
13,925
Filed 2017-09-26
Tx date 2017-09-22
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-55,510
-6,100 vol
$9.10 each
1,576,000
Filed 2017-09-19
Tx date 2017-09-18
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,418
+993 vol
$4.45 each
121,569
Filed 2017-09-19
Tx date 2017-09-18
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares - Options
52 - Expiration of options
$7,613
+1,228 vol
$6.20 each
122,797
Filed 2017-09-18
Tx date 2017-09-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,025
-1,300 vol
$9.25 each
16,621
Filed 2017-09-18
Tx date 2017-09-18
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-55,170
-6,000 vol
$9.20 each
86,100
Filed 2017-09-15
Tx date 2017-09-15
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,850
-200 vol
$9.25 each
17,921
Filed 2017-09-15
Tx date 2017-09-14
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-13,800
-1,500 vol
$9.20 each
18,121
Filed 2017-08-21
Tx date 2017-08-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
11 - Acquisition or disposition carried out privately
$8,937
+993 vol
$9.00 each
Filed 2017-08-21
Tx date 2017-08-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$8,937
+993 vol
$9.00 each
18,393
Filed 2017-08-21
Tx date 2017-08-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$11,052
+1,228 vol
$9.00 each
19,621
Filed 2017-08-21
Tx date 2017-08-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
11 - Acquisition or disposition carried out privately
$11,052
+1,228 vol
$9.00 each
Filed 2017-08-21
Tx date 2017-08-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
11 - Acquisition or disposition carried out privately
$11,052
+1,228 vol
$9.00 each
Filed 2017-08-21
Tx date 2017-08-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
11 - Acquisition or disposition carried out privately
$8,937
+993 vol
$9.00 each
Filed 2017-08-18
Tx date 2017-08-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,418
+993 vol
$4.45 each
369
Filed 2017-08-18
Tx date 2017-08-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
11 - Acquisition or disposition carried out privately
$11,052
+1,228 vol
$9.00 each
3,818
Filed 2017-08-18
Tx date 2017-08-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$7,613
+1,228 vol
$6.20 each
2,590
Filed 2017-08-18
Tx date 2017-08-18
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
11 - Acquisition or disposition carried out privately
$8,937
+993 vol
$9.00 each
1,362
Filed 2017-08-17
Tx date 2017-08-14
$RX
BioSyent Inc.
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
5,921
Filed 2017-07-05
Tx date 2015-01-12
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-05
Tx date 2017-07-04
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$65,994
+8,246 vol
$8.00 each
8,246
Filed 2017-07-05
Tx date 2017-07-04
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$70,996
+8,871 vol
$8.00 each
51,295
Filed 2017-07-04
Tx date 2017-07-04
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$66,498
+8,309 vol
$8.00 each
8,309
Filed 2017-07-04
Tx date 2016-02-12
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-04
Tx date 2017-07-04
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$47,995
+5,997 vol
$8.00 each
5,997
Filed 2017-07-04
Tx date 2016-02-12
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-04
Tx date 2017-07-04
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$139,944
+17,493 vol
$8.00 each
974,993
Filed 2017-06-21
Tx date 2017-06-21
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,830
-600 vol
$8.05 each
279,700
Filed 2017-06-21
Tx date 2017-06-21
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,100
-1,000 vol
$8.10 each
278,700
Filed 2017-06-20
Tx date 2017-06-19
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-805.00
-100 vol
$8.05 each
280,300
Filed 2017-06-16
Tx date 2017-06-16
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-7,980
-1,000 vol
$7.98 each
92,100
Filed 2017-06-14
Tx date 2017-06-12
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,610
-200 vol
$8.05 each
280,400
Filed 2017-06-13
Tx date 2017-06-13
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-15,840
-2,000 vol
$7.92 each
93,100
Filed 2017-06-08
Tx date 2017-06-08
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-15,860
-2,000 vol
$7.93 each
95,100
Filed 2017-06-06
Tx date 2017-06-06
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-15,480
-2,000 vol
$7.74 each
97,100
Filed 2017-06-03
Tx date 2017-06-01
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$3,549
+3,900 vol
$0.91 each
101,100
Filed 2017-06-03
Tx date 2017-06-01
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$3,549
+3,900 vol
$0.91 each
120,576
Filed 2017-06-02
Tx date 2017-06-02
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-15,600
-2,000 vol
$7.80 each
95,200
Filed 2017-04-04
Tx date 2014-06-13
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options

+882 vol
81,533
Filed 2017-04-04
Tx date 2014-06-12
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-80,500
-10,000 vol
$8.05 each
15,000
Filed 2017-04-04
Tx date 2017-03-31
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-13,950
-1,800 vol
$7.75 each
1,576,000
Filed 2017-04-04
Tx date 2017-03-31
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-13,950
-1,800 vol
$7.75 each
Filed 2017-04-04
Tx date 2014-08-28
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-93,000
-10,000 vol
$9.30 each
0
Filed 2017-04-04
Tx date 2017-03-30
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-38,000
-5,000 vol
$7.60 each
1,577,800
Filed 2017-04-04
Tx date 2016-12-12
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-790.00
-100 vol
$7.90 each
0
Filed 2017-04-04
Tx date 2014-06-16
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-37,500
-5,000 vol
$7.50 each
10,000
Filed 2017-04-03
Tx date 2016-09-29
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
59 - Exercise for cash
$-83,853
-9,900 vol
$8.47 each
Filed 2017-04-03
Tx date 2016-09-29
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-83,853
-9,900 vol
$8.47 each
25,100
Filed 2017-04-03
Tx date 2016-09-29
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
59 - Exercise for cash
$83,853
+9,900 vol
$8.47 each
Filed 2017-04-03
Tx date 2016-09-29
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
59 - Exercise for cash
$83,853
+9,900 vol
$8.47 each
Filed 2017-04-03
Tx date 2016-09-29
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
59 - Exercise for cash
$-83,853
-9,900 vol
$8.47 each
Filed 2017-03-31
Tx date 2017-03-31
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-6,975
-900 vol
$7.75 each
280,600
Filed 2017-03-30
Tx date 2017-03-23
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$468,650
+65,000 vol
$7.21 each
Filed 2017-03-30
Tx date 2017-03-15
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$21,675
+2,949 vol
$7.35 each
Filed 2017-03-30
Tx date 2016-09-12
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-83,000
-10,000 vol
$8.30 each
74,071
Filed 2017-03-30
Tx date 2016-09-12
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$83,000
+10,000 vol
$8.30 each
Filed 2017-03-30
Tx date 2017-03-23
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$468,650
+65,000 vol
$7.21 each
Filed 2017-03-30
Tx date 2017-03-23
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-162,772.96
-22,576 vol
$7.21 each
87,324
Filed 2017-03-30
Tx date 2017-03-23
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$162,772
+22,576 vol
$7.21 each
Filed 2017-03-30
Tx date 2017-03-15
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$21,675
+2,949 vol
$7.35 each
77,020
Filed 2017-03-30
Tx date 2017-03-23
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-468,650
-65,000 vol
$7.21 each
12,020
Filed 2017-03-27
Tx date 2017-03-23
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$468,650
+65,000 vol
$7.21 each
197,476
Filed 2017-03-24
Tx date 2017-03-20
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
10 - Acquisition or disposition in the public market
$-775.00
-100 vol
$7.75 each
-624
Filed 2017-03-24
Tx date 2017-03-23
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$162,772
+22,576 vol
$7.21 each
132,476
Filed 2017-03-24
Tx date 2017-03-23
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$468,650
+65,000 vol
$7.21 each
109,900
Filed 2017-03-20
Tx date 2017-03-17
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$29,640
+3,900 vol
$7.60 each
17,400
Filed 2017-03-20
Tx date 2017-03-15
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$20,146
+2,741 vol
$7.35 each
7,418
Filed 2017-03-20
Tx date 2017-03-17
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
11 - Acquisition or disposition carried out privately
$29,640
+3,900 vol
$7.60 each
-524
Filed 2017-03-20
Tx date 2017-03-17
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$354,900
+3,900 vol
$91.00 each
-4,424
Filed 2017-03-18
Tx date 2017-03-15
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$85,480
+11,630 vol
$7.35 each
302,874
Filed 2017-03-17
Tx date 2016-08-22
$RX
BioSyent Inc.
Montador, Paul
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$12,500
+25,000 vol
$0.50 each
Filed 2017-03-17
Tx date 2016-08-22
$RX
BioSyent Inc.
Montador, Paul
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-12,500
-25,000 vol
$0.50 each
6,676
Filed 2017-03-16
Tx date 2017-03-15
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$21,675
+2,949 vol
$7.35 each
97,020
Filed 2017-03-15
Tx date 2017-03-14
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$34,596
+4,707 vol
$7.35 each
20,025
Filed 2017-03-15
Tx date 2017-03-15
$RX
BioSyent Inc.
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$9,158
+1,246 vol
$7.35 each
7,082
Filed 2017-03-15
Tx date 2017-03-15
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$14,655
+1,994 vol
$7.35 each
3,885
Filed 2017-03-15
Tx date 2017-03-15
$RX
BioSyent Inc.
Montador, Paul
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$9,158
+1,246 vol
$7.35 each
57,922
Filed 2017-03-15
Tx date 2017-03-15
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$9,158
+1,246 vol
$7.35 each
47,922
Filed 2017-03-15
Tx date 2017-03-15
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$20,300
+2,762 vol
$7.35 each
9,880
Filed 2016-12-29
Tx date 2016-12-29
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,610
-200 vol
$8.05 each
281,500
Filed 2016-12-29
Tx date 2016-12-28
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,610
-200 vol
$8.05 each
281,700
Filed 2016-12-12
Tx date 2016-12-02
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$33,000
+300,000 vol
$0.11 each
591,244
Filed 2016-12-12
Tx date 2016-12-12
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
11 - Acquisition or disposition carried out privately
$-2,400,000
-300,000 vol
$8.00 each
291,244
Filed 2016-11-25
Tx date 2016-11-25
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,855
-1,100 vol
$8.05 each
281,900
Filed 2016-11-25
Tx date 2016-11-25
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,000
-2,000 vol
$8.00 each
283,000
Filed 2016-10-05
Tx date 2016-09-29
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
59 - Exercise for cash
$83,853
+9,900 vol
$8.47 each
44,900
Filed 2016-09-29
Tx date 2016-09-29
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,800
-2,000 vol
$8.40 each
97,200
Filed 2016-09-19
Tx date 2016-09-12
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$5,699
+10,000 vol
$0.57 each
35,000
Filed 2016-09-13
Tx date 2016-09-12
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$83,000
+10,000 vol
$8.30 each
94,071
Filed 2016-09-12
Tx date 2016-08-22
$RX
BioSyent Inc.
Montador, Paul
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$205,500
+25,000 vol
$8.22 each
Filed 2016-09-12
Tx date 2016-08-22
$RX
BioSyent Inc.
Montador, Paul
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$204,999
+25,000 vol
$8.20 each
75,000
Filed 2016-09-10
Tx date 2016-08-22
$RX
BioSyent Inc.
Montador, Paul
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$205,500
+25,000 vol
$8.22 each
75,000
Filed 2016-09-08
Tx date 2016-09-08
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-6,680
-800 vol
$8.35 each
13,500
Filed 2016-08-29
Tx date 2016-08-22
$RX
BioSyent Inc.
Montador, Paul
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$12,500
+25,000 vol
$0.50 each
56,676
Filed 2016-06-10
Tx date 2016-06-10
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-7,500
-1,000 vol
$7.50 each
14,300
Filed 2016-06-09
Tx date 2016-06-08
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,750
-1,700 vol
$7.50 each
15,300
Filed 2016-03-31
Tx date 2016-03-31
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$4,414
+992 vol
$4.45 each
152,192
Filed 2016-03-31
Tx date 2016-03-31
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$3,549
+3,900 vol
$0.91 each
151,200
Filed 2016-03-29
Tx date 2016-03-24
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$21,591
+3,100 vol
$6.96 each
1,580,800
Filed 2016-03-29
Tx date 2016-03-29
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$14,014
+2,000 vol
$7.01 each
1,582,800
Filed 2016-03-24
Tx date 2016-03-24
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-14,200
-2,000 vol
$7.10 each
99,200
Filed 2016-03-23
Tx date 2016-03-23
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-14,200
-2,000 vol
$7.10 each
101,200
Filed 2016-03-23
Tx date 2016-03-23
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,127
-300 vol
$7.09 each
103,200
Filed 2016-03-22
Tx date 2016-03-21
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-28,160
-4,000 vol
$7.04 each
103,500
Filed 2016-03-16
Tx date 2016-03-16
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-13,740
-2,000 vol
$6.87 each
107,500
Filed 2016-03-09
Tx date 2016-03-09
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-27,776
-4,000 vol
$6.94 each
109,500
Filed 2016-02-25
Tx date 2016-02-12
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$7,923
+1,278 vol
$6.20 each
1,891
Filed 2016-02-25
Tx date 2016-02-12
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$7,316
+1,180 vol
$6.20 each
Filed 2016-02-25
Tx date 2016-02-12
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$12,443
+2,007 vol
$6.20 each
7,118
Filed 2016-02-25
Tx date 2016-02-12
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
5,111
Filed 2016-02-24
Tx date 2016-02-12
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
613
Filed 2016-02-24
Tx date 2016-02-12
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$7,316
+1,180 vol
$6.20 each
1,793
Filed 2016-02-18
Tx date 2016-02-12
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$7,613
+1,228 vol
$6.20 each
-8,324
Filed 2016-02-18
Tx date 2016-02-12
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$13,658
+2,203 vol
$6.20 each
84,071
Filed 2016-02-18
Tx date 2016-02-12
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$12,796
+2,064 vol
$6.20 each
9,460
Filed 2016-02-18
Tx date 2016-02-12
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$7,613
+1,228 vol
$6.20 each
46,676
Filed 2016-02-18
Tx date 2016-02-12
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$6,398
+1,032 vol
$6.20 each
Filed 2016-02-17
Tx date 2016-02-12
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$53,053
+8,557 vol
$6.20 each
291,244
Filed 2016-02-17
Tx date 2016-02-12
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$7,613
+1,228 vol
$6.20 each
116,676
Filed 2016-02-17
Tx date 2016-02-12
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$6,398
+1,032 vol
$6.20 each
8,428
Filed 2016-02-17
Tx date 2016-02-12
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$11,780
+1,900 vol
$6.20 each
4,677
Filed 2016-02-17
Tx date 2016-02-12
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$23,857
+3,848 vol
$6.20 each
15,318
Filed 2016-02-16
Tx date 2016-02-12
$RX
BioSyent Inc.
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$7,613
+1,228 vol
$6.20 each
5,836
Filed 2016-02-16
Tx date 2016-02-12
$RX
BioSyent Inc.
Montador, Paul
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options
$7,498
+1,228 vol
$6.11 each
31,676
Filed 2016-01-21
Tx date 2016-01-13
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$33,000
+300,000 vol
$0.11 each
Filed 2016-01-21
Tx date 2016-01-13
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-33,000
-300,000 vol
$0.11 each
282,687
Filed 2016-01-20
Tx date 2016-01-13
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$33,000
+300,000 vol
$0.11 each
957,500
Filed 2016-01-18
Tx date 2016-01-13
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$33,000
+300,000 vol
$0.11 each
882,687
Filed 2016-01-15
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,400
+40,000 vol
$0.11 each
Filed 2016-01-15
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-4,400
-40,000 vol
$0.11 each
-9,552
Filed 2016-01-15
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,400
+40,000 vol
$0.11 each
Filed 2016-01-15
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,400
+40,000 vol
$0.11 each
Filed 2016-01-15
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,400
+40,000 vol
$0.11 each
Filed 2016-01-15
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,400
+40,000 vol
$0.11 each
Filed 2016-01-15
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,400
+40,000 vol
$0.11 each
Filed 2016-01-14
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,400
+40,000 vol
$0.11 each
70,448
Filed 2016-01-14
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,400
+40,000 vol
$0.11 each
150,448
Filed 2016-01-14
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$4,400
+40,000 vol
$0.11 each
110,448
Filed 2016-01-14
Tx date 2016-01-13
$RX
BioSyent Inc.
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$252,000
+40,000 vol
$6.30 each
285,000
Filed 2015-08-31
Tx date 2015-08-24
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$3,300
+30,000 vol
$0.11 each
657,500
Filed 2015-08-31
Tx date 2015-08-24
$RX
BioSyent Inc.
Goehrum, Rene Christopher
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$3,300
+30,000 vol
$0.11 each
582,687
Filed 2015-08-21
Tx date 2015-08-17
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
7,396
Filed 2015-06-27
Tx date 2015-06-23
$RX
BioSyent Inc.
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-16,200
-2,000 vol
$8.10 each
1,577,700
Filed 2015-06-22
Tx date 2015-06-22
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-32,560
-4,000 vol
$8.14 each
113,500
Filed 2015-06-19
Tx date 2015-06-17
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-32,040
-4,000 vol
$8.01 each
117,500
Filed 2015-06-15
Tx date 2015-06-15
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-32,040
-4,000 vol
$8.01 each
121,500
Filed 2015-05-28
Tx date 2015-05-21
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-454,350
-65,000 vol
$6.99 each
115,448
Filed 2015-05-28
Tx date 2015-05-21
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-454,350
-65,000 vol
$6.99 each
Filed 2015-05-26
Tx date 2015-05-21
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-454,350
-65,000 vol
$6.99 each
115,448
Filed 2015-05-26
Tx date 2015-05-21
$RX
BioSyent Inc.
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$454,350
+65,000 vol
$6.99 each
125,500